View source for Boston Scientific

{{Short description|U.S.-based medical device company}}
{{Multiple issues|
{{Third-party|date=December 2018}}
{{Advert|date=July 2024}} }}
{{use mdy dates|date=August 2023}}
{{Infobox company
| name               = Boston Scientific Corporation
| logo               = Boston Scientific Logo.svg
| logo_size          = 150px
| type               = [[Public company|Public]]
| traded_as          = {{ubl|{{NYSE|BSX}}|[[S&P 500]] component}}
| ISIN               = {{ISIN|sl=n|pl=y|US1011371077}}
| founders           = {{ubl|[[John Abele]]|[[Peter Nicholas (businessman)|Peter Nicholas]]}}
| hq_location        = [[Marlborough, Massachusetts]], U.S.<!--see coord below-->
| key_people         = {{unbulleted list|Michael F. Mahoney ([[Chairman]] and [[Chief executive officer|CEO]]) | Daniel Brennan ([[Chief financial officer|CFO]])}}
| industry           = [[Medical device]]
| products           = 
| revenue            = {{nowrap|{{increase}} {{US$|16.75 billion|link=yes}} (2024){{Sfn|"Form 10K," December 31,|2024}} }}
| operating_income   = {{increase}} {{US$|2.603 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}}
| net_income         = {{increase}} {{US$|1.853 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}}
| assets             = {{increase}} {{US$|39.39 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}}
| equity             = {{increase}} {{US$|21.77 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}}
| num_employees      = 53,000{{Sfn|"Form 10K," December 31,|2024}}
| num_employees_year = 2024
| foundation         = {{start date and age|1979|6|29}} in [[Watertown, Massachusetts]]
| website            = {{URL|bostonscientific.com}}
}}
{{Coord|42|21|37.3|N|71|33|32.6|W|display=title}}
'''Boston Scientific Corporation''' ('''BSC'''), headquartered in [[Marlborough, Massachusetts]] and incorporated in [[Delaware]],{{sfn|SEC Report|}} is an American [[biotechnology]] and [[biomedical engineering]] firm and multinational manufacturer of [[medical device]]s used in interventional [[Specialty (medicine)|medical specialties]], including [[interventional radiology]], [[interventional cardiology]], peripheral interventions, [[Neuromodulation (medicine)|neuromodulation]], neurovascular intervention, [[electrophysiology]], [[cardiac surgery]], [[vascular surgery]], [[endoscopy]], [[oncology]], [[urology]] and [[gynecology]]. Boston Scientific is widely known for the development of the Taxus [[Stent]], a [[drug-eluting stent]] which is used to open [[Vascular occlusion|clogged]] [[Artery|arteries]].{{Sfn|Wood, March 4,|2004}} With the full acquisition of [[Cameron Health]] in June 2012, the company also became notable for offering a minimally invasive [[implantable cardioverter-defibrillator]] (ICD) which they call the EMBLEM [[Subcutaneous Implantable Defibrillator (S-ICD)|subcutaneous implantable defibrillator (S-ICD)]].{{Sfn|Cameron Health, June 8,|2012}}{{Sfn|"EMBLEM S–ISC System,"|2020}}

Over the last 20 years, Boston Scientific has been involved in a number of high-profile patent infringement cases and made extensive payouts, including 1.725 billion dollars to [[Johnson & Johnson]],<ref>https://news.bostonscientific.com/news-releases?item=59210  https://www.massdevice.com/boston-scientific-settles-johnson-johnson-stent-patent-spat-17-billion/</ref> 85 million dollars to [[Nevro]]<ref>https://www.massdevice.com/boston-scientific-to-pay-nevro-85m-to-settle-rest-of-patent-litigation/</ref> and 42 million dollars to [[TissueGen]].<ref>https://www.fiercebiotech.com/medtech/boston-scientific-found-guilty-infringing-drug-eluting-stent-patent-fined-42m</ref>

== History ==
Boston Scientific was formed June 29, 1979, in Watertown, Massachusetts, as a holding company for the medical products company, Medi-Tech, Inc., and to position the company for growth in interventional medicine.{{Sfn|"About Boston Scientific"}} Medi-Tech was the brainchild of [[Itzhak Bentov]], a [[Czech Republic|Czech-born]] émigré to [[Israel]] and then to the [[United States]], who worked at the [[Arthur D. Little]] think tank in [[Cambridge, Massachusetts]], and ran a contract research company from his rented house in [[Belmont, Massachusetts]], a venture he founded in 1965 with a business friend, Dan Singer. In 1967 he was asked by [[Beth Israel Deaconess Medical Center|Boston Beth Israel Hospital]] radiologists to design a steerable, remotely controlled catheter; a series of engineering designs, polymer improvements and prototypes led to the release of a new steerable angiography catheter in 1969. That year John Abele joined the small company with an option to buy, and a year later he exercised his option with Cooper Labs as a business partner, and the operation was moved – out of Bentov's lab in the basement of the rectory of a Catholic church{{Sfn|''MassDevice'', June 9,|2010}} in [[Belmont, Massachusetts|Belmont]] – to Watertown. After a decade of steady growth, by chance Abele met Pete Nicholas in their neighborhood in [[Concord, Massachusetts]]. Their partnership hinged on Nicholas' goal to build business enterprises and Abele's predilection for the vision and potential in noninvasive surgical instrumentation; they gathered backers in the Boston banking community to buy out the Cooper Labs interest and form the new corporation.{{Cn|date=June 2024}}

Less than a year later Kimray Medical Associates (later Mansfield Scientific, Inc.) was acquired, adding vena cava filters and cardiac output computers to the product line. By 1982 a renovated mill building in Watertown was transformed into a manufacturing plant. Acquisitions continued, with Endo-Tech (Microvasive, Inc.: gastrointestinal and pulmonary) in 1981 and then Van-Tec (urology) in 1988, and an international presence was expanded. Mansfield Scientific, Microvasive, and Medi-Tech merged into Boston Scientific December 31, 1988.{{Sfn|Business Entity Summary}}

=== Initial public offering (1992) ===
On May 19, 1992, Boston Scientific launched an [[initial public offering]] of 23.5 million shares, of which 18.8 million were offered in the U.S. and 4.7 million were offered outside the U.S. The initial offering amounted to 23% of Boston Scientific's outstanding stock. The opening price was $17 per share.{{Sfn|"About Boston Scientific"}} [[Goldman, Sachs & Co.]] (lead) and [[PaineWebber Inc.]] were the [[Underwriting|underwriters]] and [[Abbott Laboratories]] held a 20% stake (23.5 million shares). The [[market capitalization]] was about $1.6 billion.{{Sfn|''Chicago Tribune'', April 4,|1992|p=2}}{{efn|Equivalent to about ${{Inflation|US|1.6|1992|r=1}}&nbsp;billion in {{Inflation/year|US}}.{{Sfn|"Consumer Price Index"}}{{Sfn|McCusker, October|1991}} }} The U.S. shares were listed on the [[New York Stock Exchange]].

=== Post–IPO ===
[[File:Taxus_stent_FDA.jpg|thumb|[[Drug-eluting stent|TAXUS™ {{nowrap|Express{{sup|2}}™}} Paclitaxel-Eluting Coronary Stent]] ]]
From 1995 through 1997, Boston Scientific increased its technology R&D and product offerings following several substantial acquisitions that included Cardiovascular Imaging Systems (intravascular ultrasound), SCIMED (cardiovascular), Vesica Medical (urology), Meadox (textile vascular prostheses), EP Technologies (cardiac ablation controllers),{{Sfn|''New York Times'', October 10,|1995|p=4D}} MinTec (abdominal aortic aneurysm grafts), Symbiosis Corporation (specialty medical product manufacture), and Target Therapeutics (on neurology).{{Sfn|Rodengen,|2001|p=163}} Boston Scientific acquired Target Therapeutics in a tax-free [[stock swap]] for about $1.1 billion, more than 10 times Target's total sales, in contrast to the usual [[Price–earnings ratio|multiple]] of 10 times earnings.{{Sfn|Lee,|2018|p=116}}

The Taxus Stent was approved in 2003 in Europe and other countries and, in the United States, by the FDA in March 2004. It was the second drug-eluting stent approved in the United States.{{Sfn|Wood, March 4,|2004}}

In April 2004 the company announced that it had exercised an exclusive option to acquire Precision Vascular Systems, Inc., as part of a series of agreements between Boston Scientific and Precision Vascular in 2002 – for an undisclosed sum.{{Sfn|Precision Vascular Systems, April 7,|2004}} In June Boston acquired Advanced Bionics Corporation for $740 million in cash, plus earn out payments.{{Sfn|Advanced Bionics Corporation, June 1,|2004}} In December Boston completed its acquisition of Advanced Stent Technologies, Inc., for $120 million payable in Boston Scientific stock, plus the possibility of future contingent payments. AST had been developing stent and stent delivery systems specifically designed to address the anatomical needs of [[coronary artery disease]] in bifurcated vessels.{{Sfn|Advanced Stent Technologies, December 16,|2004}}

In April 2005, Boston exercised an exclusive option to acquire TriVascular, Inc., for an undisclosed sum and renamed it as Boston Scientific Santa Rosa Corporation, or BSSR. TriVascular was founded in January 1998 to develop less-invasive medical devices and procedures for treating [[abdominal aortic aneurysms]], but BSC discontinued its [[endovascular aortic repair]] ([[EVAR]]) program in 2006.{{Sfn|TriVascular, April 18,|2005}}{{Sfn|''Sacramento Business Journal'', March 23,|2008}} Also, in April 2005, BSC announced it had exercised its option to acquire CryoVascular Systems, Inc., and its proprietary [[angioplasty]] device to treat atherosclerotic disease of the legs and other peripheral arteries.{{Sfn|CryoVascular Systems, April 18,|2005}} In June Boston Scientific announced that its wholly owned subsidiary, Nemo I Acquisition, Inc., had successfully acquired [[Salt Lake City]]-based Rubicon Medical Corporation, with Rubicon became a wholly owned subsidiary of Boston Scientific.{{Sfn|Rubicon Medical Corporation, June 14,|2005}}

In March 2008, BSC sold BSSR to TV2 Holding Company of [[Santa Rosa, California|Santa Rosa]]. Terms of the sale include $30 million in cash paid at the closing to BSC and a [[Warrant (finance)|warrant]] allowing BSC to purchase a minority interest in TV2.{{Sfn|TriVascular (sale of BSSR), March 31,|2008}}{{Sfn|''Sacramento Business Journal'', March 23,|2008}}

===Guidant merger===
In January 2006, the company announced an offer for its longtime competitor, [[Guidant]], for $72 per share or $25 billion.{{Sfn|Guidant, January 8,|2006}} The offer, however, was rejected. On April 21, 2006, BSC acquired [[Guidant]] for $27.2 billion. Guidant was split between BSC and [[Abbott Laboratories]].{{Sfn|''NBC News'', January 25,|2006}}{{Sfn|Guidant, April 21,|2006}} Four years later, in 2010, when moving its heart-rhythm business from its acquisition of Guidant, Boston Scientific eliminated 1300 jobs.{{Sfn|Karim, November|2012}}

===Post-merger===
In December 2007, Boston Scientific announced it would sell its Fluid Management and Venous Access businesses for $425 million to [[Avista Capital Partners]].{{Sfn|Fluid Management & Venous Access, December 13,|2007}}

In April 2008, the company acquired CryoCor, Inc., for $1.35 per share, $17.6 million in total.{{Sfn|CryoCor, May 28,|2008}}{{Sfn|CryoCor Merger, April 16,|2008}} [[Navilyst Medical]] was formed in February 2008 from Boston Scientific's Fluid Management and Vascular Access business units.{{Sfn|''Xconomy'', August 5,|2008|}}

In January 2009, Boston announced it would acquire Labcoat Limited, whose primary development was that of a development-stage drug-eluting stent – for an undisclosed sum.{{Sfn|Labcoat Ltd., January 6,|2009}}

In October 2010, the company was fined $600,000 by the US Department of Justice for paying a US Army doctor to use their devices and recommend them to others.{{Sfn|''Seattle Times'', August 13,|2011|p=}} In the same month Boston Scientific acquired Asthmatx, Inc., for $193.5 million, with payments of up to $250 million being paid on the achievement of specified revenue-based criteria through 2019.{{Sfn|Asthmatx, October 26,|2010}}

In January 2011, Boston acquired Atritech, Inc., for $100 million plus additional potential payments of up to $275 million.{{sfn|Ford, July 22,|2020}} Atritech developed a novel device called the Watchman® designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke.{{Sfn|Atritech, January 19,|2011}} In the same month, Boston Scientific acquired Intelect Medical, Inc., for $78 million{{Sfn|Intelect Medical, January 5,|2011}} and the remaining 86% of Sadra Medical, Inc., not already owned for $193 million plus contingent payments.{{Sfn|Sadra Medical, January 4,|2011}} At the same time, the business divested its neurovascular business to [[Stryker Corporation]] for $1.5 billion.{{Sfn|Neurovascular business, January 3,|2011}}

In June 2012, Boston Scientific officially acquired Cameron Health for a total sum of $1.3 billion, paid out incrementally as various revenue milestones were achieved.{{Sfn|Cameron Health, June 8,|2012}} In September the company announced it would acquire BridgePoint Medical, Inc., developer of a catheter-based system to treat coronary chronic total occlusions.{{Sfn|BridgePoint Medical, September 19,|2012}} In October, the company acquired Rhythmia Medical, Inc., developer of mapping and navigation methods for use in cardiac catheter ablations and other electrophysiology procedures.{{Sfn|Rhythmia Medical, October 8,|2012}}  A month later the business acquired catheter-based renal denervation system developer, Vessix Vascular, Inc.{{Sfn|Vessix Vascular, November 8,|2012}}

In November 2013, Boston announced it would acquire Bard EP, the [[electrophysiology]] business of [[C.R. Bard, Inc.]],{{Sfn|Bard Electrophysiology, November 1,|2013}} for $275 million.{{Sfn|C.R. Bard Electrophysiology, June 28,|2013}}

In May 2014, Boston acquired hysteroscopic intrauterine tissue removal specialist, IoGyn, Inc.{{Sfn|IoGyn, May 6,|2014}} In September, the business announced it would acquire the Interventional business of [[Bayer]].{{Sfn|Bayer Interventional Business, September 2,|2014}}

In March 2015, the company announced it would acquire [[Endo International|Endo International Plc]]'s American Medical Systems urology business for at least $1.6 billion, expanding the company's health and prostate treatments.{{Sfn|''Bloomberg News'', March 2,|2015}} In April, Boston announced its intention to acquire Xlumena, Inc.{{Sfn|Xlumena, April 1,|2015}} In October Boston announced it had invested further in percutaneous [[mitral valve replacement]] system developer, MValve Technologies, gaining a right to acquire the business in the future.{{Sfn|MValve Technologies, October 8,|2015}}

As of 2016, it operates in more than 100 countries, employs more than 24,000 people, and manufactures around 13,000 diverse products.{{Sfn|''Market Realist'', May 13,|2016}} In July 2016 the business acquired the manufacturer of radiofrequency ablation systems, Cosman Medical, Inc.{{Sfn|Cosman Medical, July 27,|2016}} In September, Boston announced it had acquired EndoChoice Holdings, Inc., becoming part of the Boston Scientific Endoscopy business for $8.00 per share or $210 million in total.{{Sfn|EndoChoice, November 22,|2016}}{{Sfn|''MassDevice'', August 27,|2016}} In November the company acquired the gynecology and urology portfolio of Distal Access, LLC, a company that designs minimally invasive medical devices.{{Sfn|Resectr™ Tissue Resection Device, November 15,|2016}} In December 2016, the business acquired a 15% stake in Neovasc, Inc., for $75 million.{{Sfn|Neovasc Advanced Biological Tissue, December 12,|2016}}

In May 2017, the company acquired Symetis SA, a developer of minimally invasive [[transcatheter aortic valve implantation]] devices.{{Sfn|Symetis, May 16,|2017}} In October Boston acquired Apama Medical Inc. for up to $300 million.{{Sfn|Apama Medical, October 2,|2017}}

In April 2018, Boston Scientific announced the triple closure of its acquisitions of women's health company, nVision Medical Corporation,{{Sfn|nVision Medical, April 16,|2018}} NxThera{{Sfn|NxThera, April 30,|2018}} and Securus Medical Group, Inc., for up to $50 million.{{Sfn|Securus Medical Group, April 3,|2018}} In July, Boston Scientific announced it would acquire Cryterion Medical, Inc,{{Sfn|Cryterion Medical, July 5,|2018}} Veniti, Inc.,{{Sfn|VENITI, August 8,|2018}} in August Augmenix, Inc., and Claret Medical, Inc.{{Sfn|Claret Medical, August 2,|2018}} and in October{{Sfn|Augmenix, October 16,|2018}} In late November Boston announce they would acquire UK medical device maker, [[BTG plc]], for $4.2 billion.{{Sfn|Keown, November 20,|2018}} BTG, before being acquired, was publicly traded and a constituent of the [[FTSE 250 Index]]. In late December, the company announced it would acquire Millipede, Inc for $325 million – after previously investing $90 million in the company.{{Sfn|Terry, December 28,|2018}}
{{Portal|Companies}}

In May 2019, the company announced it would acquire Vertiflex, Inc., with the aim of increasing its interventional pain therapy offerings. Vertiflex principally developed treatment for [[lumbar spinal stenosis]].{{Sfn|Vertiflex, May 9,|2019}}

In January 2021, Boston announced it would acquire Minneapolis-based Preventice Solutions, Inc., and its portfolio of mobile cardiac health solutions for up to $1.2 billion.{{Sfn|Preventice Solutions, January 21,|2021}} In March, the business announced it would acquire Lumenis Ltd. for $1 billion from an affiliate of [[Baring Private Equity Asia]],{{Sfn|Lumenis Surgical Business, March 3,|2021}} who, in 2019, had acquired it from XIO Group.{{Sfn|''NS Medical Devices'', November 20,|2019}} In June, the company announced it would acquire the 73% of Farapulse, Inc., it did not already own, for $295 million. Farapulse was a [[University of Iowa]] [[Startup company|startup]]. The deal complimented Boston Scientific's existing electrophysiology portfolio.{{Sfn|Farapulse, June 24,|2021}} In September, the business announced it would acquire Devoro Medical, Inc., and its blood clot capturing technology.{{Sfn|Devoro Medical, September 21,|2021}} Boston Scientific had been a strategic investor in Devoro since 2019. In October, the company announced it would acquire Baylis Medical Company Inc. for $1.75 billion, expanding its electrophysiology and heart product portfolios (see [[Frank Baylis]]).{{Sfn|''Reuters'', October 6,|2021}}{{Sfn|''Globe and Mail'', October 6,|2021}}

In June 2022, the business announced it would acquire M.I.Tech Co., Ltd., of South Korea, for around $230 million.{{Sfn|M.I.Tech Co., June 15,|2022}} The deal was cancelled in May 2023 citing regulatory hurdles.{{Sfn|''Fierce Biotech'', May 25,|2023}} In August, Boston announced it would acquire Obsidio, Inc.{{Sfn|Obsidio, August 15,|2022}}

In September 2023, Boston Scientific acquired Relievant Medsystems, Inc. for an upfront cash payment of $850 million and undisclosed additional contingent payments based on sales performance over the next three years.<ref>{{Cite press release |last= |first= |title=Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc. |url=https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-relievant-medsystems-inc-301931674.html |access-date=2023-09-19 |website=www.prnewswire.com |language=en |archive-date=September 20, 2023 |archive-url=https://web.archive.org/web/20230920213420/https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-relievant-medsystems-inc-301931674.html |url-status=live }}</ref>

In January 2024, the company announced it would acquire [[Axonics, Inc.]] for $3.7 billion.<ref>{{cite web | url=https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-axonics-inc-/?s=79 | title=Boston Scientific Announces Agreement to Acquire Axonics, Inc | date=January 8, 2024 | access-date=January 11, 2024 | archive-date=June 1, 2024 | archive-url=https://web.archive.org/web/20240601135109/https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-axonics-inc-/?s=79 | url-status=live }}</ref>

{{hidden begin|border=1px  #aaa solid|title=Boston Scientific mergers & acquisitions|ta1=center}}
{{Tree list}}
*'''Boston Scientific'''
**Precision Vascular Systems, Inc. <small>(Acq 2004)</small>
**Advanced Bionics Corporation <small>(Acq 2004)</small>
**Advanced Stent Technologies, Inc. <small>(Acq 2004)</small>
**TriVascular, Inc. <small>(Acq 2005)</small>
**CryoVascular Systems, Inc. <small>(Acq 2005)</small>
**Nemo I Acquisition, Inc.
***Rubicon Medical Corporation <small>(Acq 2005)</small>
**[[Guidant]] <small>(Acq 2006 and split between Boston and [[Abbott Laboratories]])</small>
**CryoCor, Inc. <small>(Acq 2008)</small>
**Labcoat Limited <small>(Acq 2009)</small>
**Asthmatx, Inc. <small>(Acq 2010)</small>
**Atritech, Inc. <small>(Acq 2011)</small>
**Intelect Medical, Inc. <small>(Acq 2011)</small>
**Sadra Medical, Inc. <small>(Acq 2011)</small>
**Cameron Health <small>(Acq 2012)</small>
**BridgePoint Medical, Inc. <small>(Acq 2012)</small>
**Rhythmia Medical, Inc. <small>(Acq 2012)</small>
**Vessix Vascular, Inc. <small>(Acq 2012)</small>
**Bard EP <small>(Acq 2013)</small>
**IoGyn, Inc. <small>(Acq 2014)</small>
**[[Bayer]] <small>(Interventional business, Acq 2014)</small>
**[[Endo International]] <small>(Urology business, Acq 2015)</small>
**Xlumena, Inc. <small>(Acq 2015)</small>
**Cosman Medical, Inc. <small>(Acq 2016)</small>
**EndoChoice Holdings, Inc. <small>(Acq 2016)</small>
**Distal Access, LLC <small>(Gynecology and Urology business, Acq 2016)</small>
**Symetis SA <small>(Acq 2017)</small>
**Apama Medical Inc. <small>(Acq 2017)</small>
**nVision Medical Corporation <small>(Acq 2018)</small>
**NxThera <small>(Acq 2018)</small>
**Securus Medical Group, Inc. <small>(Acq 2018)</small>
**Cryterion Medical, Inc. <small>(Acq 2018)</small>
**Veniti, Inc. <small>(Acq 2018)</small>
**Augmenix, Inc. <small>(Acq 2018)</small>
**Claret Medical, Inc. <small>(Acq 2018)</small>
**[[BTG plc]] <small>(Acq 2018)</small>
***British Technology Group <small>(Merged 1981)</small>
****[[National Research Development Corporation]] (NRDC) <small>(Est. 1948)</small>
****[[National Enterprise Board]] (NEB) <small>(Est. 1975)</small>
***Protherics Plc <small>(Acq 2008)</small>
***[[Biocompatibles]] <small>(Acq 2011)</small>
***Galil Medical <small>(Acq 2016)</small>
***Novate Medical <small>(Acq 2018)</small>
**Millipede, Inc. <small>(Acq 2018)</small>
**Vertiflex, Inc. <small>(Acq 2019)</small>
**Preventice Solutions, Inc. <small>(Acq 2021)</small>
**Lumenis Ltd <small>(Acq 2021)</small>
**Farapulse, Inc <small>(Acq 2021)</small>
**Devoro Medical, Inc. <small>(Acq 2021)</small>
**Baylis Medical Company Inc <small>(Acq 2021)</small>
**Obsidio <small>(Acq 2022)</small>
**Relievant Medsystems, Inc. <small>(Acq 2023)</small>
**Apollo Endosurgery, Inc <small>(Acq 2023)</small>
**Axonics, Inc. <small>(Acq 2024)</small>
**SoniVie Ltd <small>(Acq 2025)</small>
{{Tree list/end}}
{{hidden end}}

==Organizational culture==
BSC has been assessed favorably by its employees. In ''[[Glassdoor]]'' annual ''Best Places to Work – Employee's Choice Survey'', BSC earned scores of:
* 2018: #35 (of 100). 4.4 stars (of 5).{{Sfn|''Glassdoor''|2018}}
* 2019: #56 (of 100). 4.3 stars (of 5).{{Sfn|''Glassdoor''|2019}}
* 2022: #52 (of 100). 4.3 stars (of 5).{{Sfn|''Glassdoor''|2022}}
The feedback for this survey is given by current and former employees. As of 2018, BSC had 43% women among its employees, 38% among management positions, and 23% among corporate top management positions (data for US workforce, as of 2018).{{Sfn|''Working Mother''|2018}}

===Social commitment===
Boston Scientific has set a standard for implementing an integrative organizational culture and states that it actively strives to further improve this by, among other things, increasing diversity among its employees – and in particular, among its managers, executives, and directors. To this end, the company has set itself the following goals in 2018:{{Sfn|"Diversity & Inclusion"}}{{Sfn|"2021 Performance Report"}}
* Leadership role by belonging to the top 10 companies in the integration of employees of the following groups: [[women]], [[people of color]], disabled persons and members of the [[LGBTQ]] community.
* Increase the proportion of people of color with supervisor or managerial functions to 20% in the USA including Puerto Rico (end of 2018: 19.6%, +1.8% compared to 2017).
* Increase the proportion of women in supervisor or managerial positions to 40% worldwide (end of 2018: 38.4%, +1.0% against 2017).

Success for these objectives has been chronicled and ranked by publications and organizations, including:
* ''[[Forbes]]'' added the company in 2019 to its list of ''Best Employers For Diversity'' for its efforts to foster a corporate culture that welcomes and supports all employees. That year, BSC ranked 85th out of 500 companies.{{Sfn|''Forbes'', January 19,|2019}} ''Forbes'' included BSC in its 2021 and 2022 lists as well – ranking it 6th in 2021 and 171st in 2022, out of 500 for both years.{{Sfn|Diversity, May 2,|2022}}{{Sfn|''3BL CSRwire'', May 5,|2022}}
* ''[[Bloomberg News|Bloomberg]]'' recognized BSC for its inclusion in the ''Gender-Equality Index'' in 2019, which includes companies that publicly demonstrate their commitment to equality and the advancement of women in the workplace. The index lists a total of 230 companies from ten economic sectors and 36 countries and regions.{{Sfn|Bloomberg – "Gender-Equality Index"}}
* The US magazine ''[[Working Mother]]'', in 2017, listed BSC, for the first time, along with 9 other companies, as one of the "100 Best Companies for ''Working Mothers''."{{Sfn|''Working Mother''|2017}} The publication, again, listed BSC in 2018, 2019, and 2020.<ref>{{harvs|nb|author=''Working Mother'' |year=2018 |year2=2019 |year3=2020}}</ref>
* The [[Human Rights Campaign]] ("HRC") named BSC as a ''Best Place to Work for LGBTQ Equality'' in its 2019 edition of the eponymous list. HRC has given BSC a ranking of 100 (of 100) every year from 2015 through 2022 in its annual CEI Index (Corporate Equality Index) rankings of [[Fortune 1000]] companies.{{Sfn|Human Rights Campaign}}
* The journal, ''US Black Engineer & Information Technology'' (''USBE & IT''), in its "2021 Top Supporters of [[HBCU]] Engineering," ranked BSC No. 6 among the "Top 20 Industry Supporters."{{Sfn|Deen,|2021}}

== Litigation ==
===Johnson & Johnson patent litigation===
Beginning in 2003, Boston Scientific and [[Johnson & Johnson]] were involved in a series of litigations involving patents covering [[heart stent]] medical devices. Both parties claimed that the other had infringed upon their patents. The litigation was settled once Boston Scientific agreed to pay $716&nbsp;million to Johnson & Johnson in September 2009 and an additional $1.73&nbsp;billion in February 2010.{{Sfn|''Wall Street Journal'', February 2,|2010}}

It was announced in November 2014 that [[Johnson & Johnson]] would have another chance for payback after a multibillion-dollar trial was set for November 20, 2014. A [[New York (state)|New York]] federal court judge would hear the case without a jury to decide whether Boston Scientific should be held liable for the contract breach.{{Sfn|''Reuters'', November 19,|2014}}

===Transvaginal mesh===
Boston Scientific is one of several manufacturers of a medical device called transvaginal mesh, a type of [[surgical mesh]] used to treat [[pelvic organ prolapse]]. Experts concluded that the medical company had used cheap, counterfeit resin, which was both toxic and degraded when exposed to oxygen.{{Sfn|''CBS News'', April 17,|2019}}{{Sfn|''CNN Business'', January 14,|2016}} When this was announced on ''[[60 Minutes]],'' Boston Scientific responded by saying the broadcast was "irresponsible and misleading,"{{Sfn|''MassDevice'', May 14,|2018}} citing a 2017 [[Food and Drug Administration]] (FDA) report stating that although they found variability in the polypropylene resin, "these differences do not present new safety or effectiveness concerns."{{Sfn|APOPS, May 14,|2018}} One woman, who sued in 2011, was awarded $100 million. Two operations had failed to remove all the parts of the mesh and she was still in pain. The company appealed the decision and had the amount reduced to $10M.{{Sfn|''Reuters'', October 9,|2015}} In 2015, Boston Scientific announced it would pay $119 million to 2,970 lawsuit plaintiffs, who had been injured by the mesh.{{Sfn|''Reuters'', May 28, 2015}} On March 23, 2021, the company agreed to pay $189 million to settle allegations that it had seriously misrepresented the risks related to the vaginal mesh.{{Sfn|''MedTech Intelligence'', March 23,|2021}} As of Jan. 27, 2021, around 54,000 lawsuits related to transvaginal meshes had been filed against Boston Scientific.{{Sfn|''Boston Business Journal'', March 23,|2021}}

In April 2019, the FDA ordered Boston Scientific and Coloplast to remove all of their vaginal mesh products from the United States market.{{Sfn|''MedTech Intelligence'', March 23,|2021}}

In 2020, Johnson & Johnson was required to pay $344 million for failing to disclose the serious product risks of its transvaginal mesh product.{{Sfn|''MedTech Intelligence'', March 23,|2021}}

=== NIR stent ===
In 2005, Boston Scientific paid $74 million to settle allegations that it had continued to sell NIR stents (flexible stents) after learning that many of them were defective. Twenty-six injuries and one death may have been caused by malfunctioning stents.{{Sfn|''Boston'', June 21,|2011}}

=== Defective defibrillators ===
[[File:Implantable cardioverter-defibrillator.jpg|thumb|Guidant Vitalilty™ AVT™ implantable cardioverter-defibrillator – Model A135 (The model illustrated was not the subject of the charge.)]]
In 2011, Guidant, a subsidiary of Boston Scientific, was criminally convicted of a failure to report defibrillator safety problems to the FDA.{{Sfn|U.S. Department of Justice, January 12,|2011}} The company was forced to pay more than $296 million in criminal fines and had to submit to the supervision of the U.S. Probation Office for three years. Even though Guidant knew the devices were defective, they continued to sell the defibrillators anyway.{{Sfn|U.S. Department of Justice, January 27,|2011}} Guidant LLC had also advised its sales representatives to tell physicians that nothing was wrong with the defibrillators, and told the FDA that the proposed corrections were not being done to correct life-threatening device flaws, but were rather to improve process throughout. Not until three deaths had occurred and ten months had passed did the company reveal the defects in 2005. The directives for these wrongdoings had been implemented prior to Boston Scientific's acquisition of Guidant in 2006.{{Sfn|''MassDevice'', April 6,|2010}}

In 2013, BSC and three of its subsidiaries – Guidant LLC, Guidant Sales LLC, and Cardiac Pacemakers, Inc. – agreed to pay $30 million to settle allegations that, according to the [[U.S. Department of Justice|Justice Department]], between 2002 and 2005, Guidant knowingly sold defective heart devices to health care facilities that in turn implanted the devices into [[Medicare (United States)|Medicare]] patients.{{Sfn|Strom, January 25,|2020}}{{Sfn|GlobalData, June|2022}}

=== Bribery allegations ===
In 2009, Boston Scientific agreed to pay $22 million to settle allegations that its subsidiary Guidant LLC had used kickback schemes to boost sales for its pacemakers (cardiac rhythm management or CRM devices) and defibrillators ([[implantable cardioverter-defibrillators]] or ICD devices). Allegedly, Guidant paid doctors between $1,000 and $1,500 each to participate in one of its four post-studies known as RaCE ($1,500), RaCE II ($1,000), RaCE III ($1,000), and MERITS ($1,000).{{Sfn|''MassDevice'', December 23,|2009}}

== Obsidio Embolic Recall ==
In April 2024, the FDA announced a recall of Boston Scientific's device, Obsidio Embolic, which is used to stop hemorrhaging and excessive bleeding. It has been found that when the device is paired with the aliquot technique, it can lead to bowel ischemia, which can mean longer hospitalization or death for patients.<ref>{{Cite web |date=April 17, 2024 |title=FDA classifies recall of Boston Scientific device as 'most serious' |url=https://www.reuters.com/business/healthcare-pharmaceuticals/fda-classifies-recall-boston-scientific-device-treat-hemorrhaging-most-serious-2024-04-17/ |access-date=April 23, 2024 |website=Reuters |archive-date=April 18, 2024 |archive-url=https://web.archive.org/web/20240418062949/https://www.reuters.com/business/healthcare-pharmaceuticals/fda-classifies-recall-boston-scientific-device-treat-hemorrhaging-most-serious-2024-04-17/ |url-status=live }}</ref>

== Financial restatement ==
On November 3, 1998, Boston Scientific restated its financial results for 1997, as well as its quarterly results for the first three quarters of 1998, due to the occurrence of business irregularities in the operations of its Japanese subsidiary.{{Sfn|Irregularities in Japanese Subsidiary, November 3,|1998}}

==Notable people==
{{div col|colwidth=50em}}
* {{hanging indent |text=[[Donald Steven Baim]], MD (1946–2009), served Chief Medical and Scientific Officer for Boston Scientific from 2006 until his death in 2009.}}
* {{hanging indent |text=[[Ian Meredith]], MD, PhD, [[Member of the Order of Australia|AM]] (born 1956), has been Global Chief Medical Officer and Executive Vice President since January 2017.}}
* {{hanging indent |text=[[Ursula Burns]] (born 1958), who served as a Member of Boston Scientific's 13-seat Board of Directors since 2002, resigned after being named Chief Executive Officer of the [[Xerox Corporation]], taking effect July 1, 2009, and becoming the first African-American female CEO of a ''[[Fortune 500]]'' company.}}
* {{hanging indent |text=[[Kristina M. Johnson]] (born 1957), PhD, who served as a Member of BSC's Board since May 2006, resigned in May 2009 after being [[List of positions filled by presidential appointment with Senate confirmation|confirmed by the U.S. Senate]] to serve as Under Secretary in the Department of Energy (see [[Under Secretary of Energy for Infrastructure]] & [[Under Secretary of Energy for Science and Innovation]]). Johnson was re-elected to BSC's board January 1, 2011, and served in that position until May 2017.}}
* {{hanging indent |text=[[Yoshiaki Fujimori]] (born 1951), BSC Board Member since July 2016.}}
* {{hanging indent |text=James Robert Tobin, Jr. (born 1944), President & CEO of BSC from 1999 through 2009.}}
* {{hanging indent |text=John Raymond Elliott "Ray" (born 1950), served as a Board Member from September 2007 to 2009, then, in July 2009, re-joined the Board and became President & CEO, a position he held until December 31, 2011. Before, he had served as Chairman of [[Zimmer Biomet|Zimmer Holdings, Inc.]], from August 6, 2001, to November 30, 2007, and President & CEO from March 20, 2001, to May 2007.}}
{{div col end}}

== Locations ==
===Headquarters and regional centers===
* World headquarters: [[Marlborough, Massachusetts]]
* Europe headquarters: [[Voisins-le-Bretonneux]], France
* Asia Pacific headquarters: Boston Scientific Asia Pacific Pte Ltd., [[Singapore]]
* U.S. Government Affairs office: [[Washington, D.C.]]
* Latin America headquarters: [[Weston, Florida]]

=== Manufacturing plants ===
*United States
** [[California]]
*** [[San Jose, California|San Jose]]
*** [[Valencia, California|Valencia]]
** [[Indiana]]
***[[Spencer, Indiana|Spencer]]
**[[Minnesota]]
*** [[Arden Hills, Minnesota|Arden Hills]]
*** [[Maple Grove, Minnesota|Maple Grove]]
**[[Georgia (U.S. state)|Georgia]]
***[[Alpharetta]]
**[[Puerto Rico]]
***[[Dorado, Puerto Rico|Dorado]]
*[[Malaysia]] 
**[[Penang, Malaysia]]
*[[Costa Rica]]
**[[Coyol]]
**[[Heredia, Costa Rica|Heredia]]
**[[Cartago, Costa Rica|Cartago]]
* [[Ireland]]
** [[Clonmel]]
** [[Cork (city)|Cork]]
** [[Galway, Ireland|Galway]]

=== Customer fulfillment centers ===
* [[Quincy, Massachusetts]]
* [[Kerkrade]], Netherlands
* [[Tokyo]], Japan

=== Institutes for Advancing Science ===
* [[Warsaw, Poland]]
* [[Minneapolis–Saint Paul]] area
** [[Arden Hills, Minnesota|Arden Hills]]
** [[Maple Grove, Minnesota|Maple Grove]]
* [[Huangpu District, Shanghai]]
* [[Japan]]
** [[Miyazaki, Japan|Miyazaki]]
** [[Tokyo, Japan|Tokyo]]
* [[Paris, France]]
* [[Gurgaon, India]]
* [[Istanbul, Turkey]]
* [[Bryanston, Gauteng|Bryanston]], [[Johannesburg]], South Africa

In June 2022, Boston Scientific announced that it would invest $62.5 million in a manufacturing and [[Supply chain management|supply chain]] facility in [[Johns Creek, Georgia]], a suburb of [[Atlanta, Georgia|Atlanta]].{{Sfn|''Atlanta Journal-Constitution'', June 28,|2022}}{{Sfn|''Atlanta Business Chronicle'', June 30,|2022}} In 2016, Boston Scientific had acquired EndoChoice, located in [[Alpharetta, Georgia|Alpharetta]], {{convert|10.8|mi|km|abbr=on}} from its proposed Johns Creek facility.

== Subsidiaries ==
BSC, as of December 31, 2019, wholly owns or has a majority interest in all of the below mentioned entities.{{Sfn|''BSC Annual Report'',|2020|loc=Exhibit 21}}
{{div col|colwidth=25em}}
* Acurate Industria e Comercio Ltda. (Brazil)
* American Medical Systems Europe B.V. (Netherlands)
* Apama Medical, Inc. (Delaware)
* Augmenix K.K. (Japan)
* Augmenix, Inc. (Delaware)
* Biocompatibles International Limited (England)
* Biocompatibles UK Limited (England)
* Biocompatibles, Inc. (Delaware)
* {{hanging indent |text=Boston Scientific (Malaysia) Sdn. Bhd. (Malaysia)}}
* {{hanging indent |text=Boston Scientific (South Africa) Proprietary Limited (South Africa)}}
* Boston Scientific (Thailand) Ltd. (Thailand)
* Boston Scientific (UK) Limited (England)
* Boston Scientific AG (Switzerland)
* Boston Scientific Argentina S.A. (Argentina)
* {{hanging indent |text=Boston Scientific Asia Pacific Pte. Ltd. (Singapore)}}
* Boston Scientific Benelux NV (Belgium)
* Boston Scientific Canada Limited (Canada)
* Boston Scientific Ceska republika s.r.o. (Czech Republic)
* Boston Scientific Chile SpA (Chile)
* Boston Scientific Clonmel Limited, in liquidation (Ireland)
* Boston Scientific Colombia Limitada (Colombia)
* {{hanging indent |text=Boston Scientific Comercial de Costa Rica BSCR, S.R.L. (Costa Rica)}}
* Boston Scientific Cork Limited, in liquidation (Ireland)
* Boston Scientific de Costa Rica S.R.L. (Costa Rica)
* Boston Scientific de Mexico, S.A. de C.V. (Mexico)
* Boston Scientific del Caribe, Inc. (Puerto Rico)
* Boston Scientific do Brasil Ltda. (Brazil)
* Boston Scientific Far East B.V. (Netherlands)
* Boston Scientific Gesellschaft m.b.H. (Austria)
* Boston Scientific Group plc (Ireland)
* Boston Scientific Hellas S.A. (Greece)
* Boston Scientific Hong Kong Limited (Hong Kong)
* Boston Scientific Iberica, S.A. (Spain)
* Boston Scientific India Private Limited (India)
* Boston Scientific International B.V. (Netherlands)
* Boston Scientific International Finance Limited (Ireland)
* Boston Scientific International S.A. (France)
* Boston Scientific Ireland Limited, in liquidation (Ireland)
* Boston Scientific Israel Ltd. (Israel)
* {{hanging indent |text=Boston Scientific Japan K.K. (Japan), [[Tokyo, Japan]] (wholly owned subsidiary)}}
* Boston Scientific Korea Co., Ltd. (Korea)
* Boston Scientific Lebanon SAL (Lebanon)
* Boston Scientific Limited (England)
* Boston Scientific Limited (Ireland)
* Boston Scientific Ltd./Boston Scientifique Ltee. (Canada)
* {{hanging indent |text=Boston Scientific Medical Device (Malaysia) Sdn. Bhd. (Malaysia)}}
* Boston Scientific Medical Device Limited (Ireland)
* Boston Scientific Medizintechnik GmbH (Germany)
* Boston Scientific Middle East FZ-LLC (UAE)
* Boston Scientific Middle East SAL (Offshore) (Lebanon)
* Boston Scientific Nederland B.V. (Netherlands)
* {{hanging indent |text=Boston Scientific Neuromodulation Corporation (Delaware), headquartered in [[Valencia, California]], founded 1993}}
* Boston Scientific New Zealand Limited (New Zealand)
* Boston Scientific Nordic AB (Sweden)
* Boston Scientific Peru S.A.C. (Peru)
* Boston Scientific Philippines, Inc. (Philippines)
* Boston Scientific Polska Sp. z o.o. (Poland)
* {{hanging indent |text=Boston Scientific Portugal - Dispositivos Medicos, Lda (Portugal)}}
* Boston Scientific Pty Ltd (Australia)
* Boston Scientific Romania S.R.L. (Romania)
* Boston Scientific S.A.S.(France)
* Boston Scientific S.p.A. (Italy)
* {{hanging indent |text=Boston Scientific Scimed, Inc. (Minnesota), headquartered in [[Maple Grove, Minnesota]]}}
* Boston Scientific Services Private Limited (India)
* {{hanging indent |text=Boston Scientific Technology & Engineering Services Private Limited (India)}}
* {{hanging indent |text=Boston Scientific TIP Gerecleri Limited Sirketi (Turkey)}}
* Boston Scientific Uruguay S.A. (Uruguay)
* {{hanging indent |text=Boston Scientific Vietnam Company Limited (Vietnam)}}
* Bravo Bidco Limited (England)
* {{hanging indent |text=BSC International Medical Trading (Shanghai) Co., Ltd. (China)}}
* {{hanging indent |text=BSC Medical Device Technology (Shanghai) Co., Ltd. (China)}}
* BTG Australasia Pty Ltd (Australia)
* BTG Europe B.V. (Netherlands)
* BTG IM Holdings Ltd. (Israel)
* BTG International (Holdings) Limited (England)
* BTG International Asia Limited (Hong Kong)
* BTG International Canada Inc. (Canada)
* BTG International Germany GmbH (Germany)
* BTG International Healthcare Inc. (Delaware)
* BTG International Healthcare Limited (Delaware)
* BTG International Healthcare LLC (Delaware)
* BTG International Inc. (Delaware)
* BTG International Limited (England)
* BTG Limited (England)
* BTG Management Services Limited (England)
* BTG Medikal Limited Sirketi (Turkey)
* {{hanging indent |text=[[Cardiac Pacemakers, Inc.]] (Minnesota), headquartered in [[Saint Paul, Minnesota]] (publicly traded)}}
* {{hanging indent |text=CeloNova BioSciences Germany GmbH, in liquidation (Germany)}}
* Claret Medical, Inc. (Delaware)
* {{hanging indent |text=Cosman Medical, LLC (Massachusetts), based in  [[Marlborough, Massachusetts|Marlborough]] and [[Burlington, Massachusetts]]}}
* Cryterion Medical, Inc. (Delaware)
* Cryterion Medical Ireland, Limited (Ireland)
* EKOS LLC (Delaware)
* Electron Acquisition Corporation (Delaware)
* EMcision International Inc. (Canada)
* EndoChoice GmbH, in liquidation (Germany)
* EndoChoice Holdings, Inc. (Delaware)
* {{hanging indent |text=EndoChoice, Inc. (Delaware), based in  [[Alpharetta, Georgia]]}}
* EndoChoice Innovation Center Ltd. (Israel)
* EndoChoice Israel Ltd. (Israel)
* {{hanging indent |text=EP Technologies, Inc. (Delaware), based in [[Sunnyvale, California]]}}
* Galil Medical Inc. (Delaware)
* Galil Medical Ltd. (Israel)
* Galil Medical UK Limited (England)
* {{hanging indent |text=Guidant Delaware Holding Corporation (Delaware)}}
* Guidant Europe NV (Belgium)
* Guidant Puerto Rico B.V. (Netherlands)
* Hong Kong Medtech Trading Limited (Hong Kong)
* Millipede, Inc. (Delaware)
* Notebook Merger Sub, Ltd. (Delaware)
* Novate Medical Limited (Ireland)
* nVision Medical Corporation (Delaware)
* NXT Merger Corp. (Delaware)
* NxThera, Inc. (Delaware)
* PneumRx GmbH (Germany)
* PneumRx Limited (England)
* PneumRx LLC (Delaware)
* Protherics Medicines Development B.V. (Netherlands)
* Protherics Medicines Development Limited (England)
* Protherics UK Limited (England)
* Provensis Limited (England)
* PT Boston Scientific Indonesia (Indonesia)
* RMI Acquisition Corp. (California)
* {{hanging indent |text=Robert S. Smith, M.D., Inc. (Georgia), based in [[Alpharetta, Georgia]]}}
* Roxwood Medical, Inc. (Delaware)
* {{hanging indent |text=Sadra Medical, Inc. (Delaware), based in [[Los Gatos, California]], founded 2003}}
* Securus Medical Group, Inc. (Delaware)
* SNS Merger Corp (Delaware)
* Special K Merger Corp. (Delaware)
* StarMedTec GmbH, in liquidation (Germany)
* Stream Enterprises LLC (Delaware)
* Symetis SA (Switzerland)
* {{hanging indent |text=Target Therapeutics, Inc. (Delaware), headquartered in [[Fremont, California]], founded 1991}}
* Veniti, Inc. (Delaware)
* Vertiflex, Inc. (Delaware)
* Zuma Investment Pty Ltd (Australia)
* 34 Biomedical Merger Corp. (Delaware)
* 9357-1867 Quebec Inc. (Canada)
{{div col end}}

==Bibliography==
=== Notes ===
{{notelist}}
{{reflist|22em}}

=== References ===
{{hanging indent |text='''Books, journals, reports (alphabetical by author)'''}}
{{refbegin|30em|indent=yes}}
<!--H-->
* {{cite book |last1=Human Rights Campaign |author-link1=Human Rights Campaign |title=Corporate Equality Index}}
<ol type="i" start="1">
<li> {{hanging indent |text={{cite book |title=2013 |date=8 January 2013 |url=https://issuu.com/humanrightscampaign/docs/corporateequalityindex_2013 |access-date=July 8, 2022 |archive-date=July 8, 2022 |archive-url=https://web.archive.org/web/20220708004722/https://issuu.com/humanrightscampaign/docs/corporateequalityindex_2013 |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2014 |url=https://assets2.hrc.org/files/assets/resources/CEI_2014_final_draft_7.pdf |access-date=July 8, 2022 |archive-date=September 1, 2022 |archive-url=https://web.archive.org/web/20220901054424/http://assets2.hrc.org/files/assets/resources/CEI_2014_final_draft_7.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2015 |url=https://assets2.hrc.org/files/documents/CEI-2015-rev.pdf |access-date=July 8, 2022 |archive-date=June 12, 2022 |archive-url=https://web.archive.org/web/20220612044035/http://assets2.hrc.org/files/documents/CEI-2015-rev.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2016 |url=https://assets2.hrc.org/files/assets/resources/CEI-2016-FullReport.pdf |access-date=July 8, 2022 |archive-date=August 12, 2022 |archive-url=https://web.archive.org/web/20220812100121/http://assets2.hrc.org/files/assets/resources/CEI-2016-FullReport.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2017 |url=https://assets2.hrc.org/files/assets/resources/CEI-2017-FinalReport.pdf |access-date=July 8, 2022 |archive-date=July 2, 2022 |archive-url=https://web.archive.org/web/20220702194831/https://assets2.hrc.org/files/assets/resources/CEI-2017-FinalReport.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2018 |url=https://assets2.hrc.org/files/assets/resources/CEI-2018-FullReport.pdf |access-date=July 8, 2022 |archive-date=July 2, 2022 |archive-url=https://web.archive.org/web/20220702210923/https://assets2.hrc.org/files/assets/resources/CEI-2018-FullReport.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2019 |url=https://assets2.hrc.org/files/assets/resources/CEI-2019-FullReport.pdf |access-date=July 8, 2022 |archive-date=April 23, 2021 |archive-url=https://web.archive.org/web/20210423185243/https://assets2.hrc.org/files/assets/resources/CEI-2019-FullReport.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2020 |url=https://hrc-prod-requests.s3-us-west-2.amazonaws.com/CEI-2020.pdf |access-date=July 6, 2022 |archive-date=January 20, 2022 |archive-url=https://web.archive.org/web/20220120112341/https://hrc-prod-requests.s3-us-west-2.amazonaws.com/CEI-2020.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2021 |url=https://hrc-prod-requests.s3-us-west-2.amazonaws.com/cei-appentix-employer-ratings.pdf |access-date=July 6, 2022 |archive-date=January 19, 2022 |archive-url=https://web.archive.org/web/20220119043048/https://hrc-prod-requests.s3-us-west-2.amazonaws.com/cei-appentix-employer-ratings.pdf |url-status=live }} }}</li>
<li> {{hanging indent |text={{cite book |title=2022 |url=https://hrc-prod-requests.s3-us-west-2.amazonaws.com/CEI-2022-Appendices-F.pdf |access-date=July 6, 2022 |archive-date=July 5, 2022 |archive-url=https://web.archive.org/web/20220705230351/https://hrc-prod-requests.s3-us-west-2.amazonaws.com/CEI-2022-Appendices-F.pdf |url-status=live }} }}</li>
</ol>
<!--G-->
* {{cite book |ref={{SfnRef|GlobalData, June|2022}} |title=''[[GlobalData]]'' }}
<ol type="i" start="1">
<li> {{hanging indent |text={{cite book |date=June 2022 |title=Pharmaceuticals & Healthcare – Deals and Alliances Profiles. |chapter=Boston Scientific Corp (BSX) |series=Report Code GDPH519D }} {{ProQuest|2479649577}} (ABI/INFORM Collection); {{OCLC|1316314935|show=all}}.}}</li>
<li> {{hanging indent |text={{cite book |date=June 2022 |title=Medical Devices Product Pipeline Summary |chapter=Boston Scientific Corp (BSX) |series=Report Code GDME519PR }} {{ProQuest|2455689963}} (ABI/INFORM Collection); {{OCLC|1264916328|show=all}}.}}</li>
</ol>
<!--K-->
* {{cite journal |ref={{SfnRef|Karim, November|2012}} |last1=Karim |first1=Samina |date=November 2014 |title=Exploring Structural Embeddedness of Product Market Activities and Resources Within Business Units |journal=[[Strategic Organization (journal)|Strategic Organization]] |volume=10 |issue=4 |pages=333–365 |doi=10.1177/1476127012457981 |s2cid=153835662 |issn=1476-1270 |jstor=43581880 |ssrn=2008240}} or {{doi|10.2139/ssrn.2008240}}
<!--L-->
* {{cite book |ref={{SfnRef|Lee,|2018|p=116}} |last1=Lee |first1=Jen-Shih |date=December 6, 2018 |title=Being a Biomedical Entrepreneur – Growth of the Biomedical Industry |url=https://books.google.com/books?id=bdWEDwAAQBAJ&pg=PA116 |publisher=[[World Scientific]] |page=116 |oclc=1121389723 |isbn=978-9-8132-7044-2 |access-date=July 6, 2022 |via=[[Google Books]] |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135109/https://books.google.com/books?id=bdWEDwAAQBAJ&pg=PA116#v=onepage&q&f=false |url-status=live }}
<!--M-->
* {{cite journal |ref={{SfnRef|McCusker, October|1991}} |last1=McCusker |first1=John James |author-link1=John J. McCusker |date=October 1991 |title=How Much Is That in Real Money? A Historical Commodity Price Index for Use as a Deflator of Money Values in the Economy of the United States |journal=[[Proceedings of the American Antiquarian Society]] |volume=101 |issue=Part 2 |url=https://www.americanantiquarian.org/proceedings/44517778.pdf |pages=297–373 |access-date=July 6, 2022 |oclc=1105608998 |archive-date=August 8, 2023 |archive-url=https://web.archive.org/web/20230808181246/https://www.americanantiquarian.org/proceedings/44517778.pdf |url-status=live }}
<ol type="i" start="1">
<li> {{cite web |date=October 1996 |title=Addenda et Corrigenda |url=https://www.americanantiquarian.org/proceedings/44525121.pdf |pages=327–334 |volume=106 |issue=Part 2 |oclc=53347080 |access-date=July 6, 2022 |archive-date=October 9, 2015 |archive-url=https://web.archive.org/web/20151009214542/https://www.americanantiquarian.org/proceedings/44525121.pdf |url-status=live }}</li></ol>
<!--R-->
* {{cite book |ref={{SfnRef|Rodengen,|2001|p=163}} |last1=Rodengen |first1=Jeffrey Lee |editor-last1=VanZile |editor-first1=Jon |date=2001 |title=The Ship in the Balloon: The Story of Boston Scientific and the Development of Less-Invasive Medicine |url=https://archive.org/details/shipinballoonsto0000rode/page/162/mode/2up |url-access=registration |publisher=Write Stuff Enterprises, Inc. |pages=161–187 |isbn=9780945903505 |lccn=97062158 |oclc=709541908 |access-date=June 22, 2022 |via=[[Internet Archive]] }}
{{refend}}

{{hanging indent |text='''Magazines, websites (alphabetical by publication/website)'''}}
{{refbegin|30em|indent=yes}}
<!--A-->
* ''APOPS''
** {{Cite web |ref={{SfnRef|''APOPS'', May 14,|2018}} |date=May 14, 2018 |title=''60 Minute'' Mesh Expose: One-Sided Noise Generates Fear on Mother's Day |website=APOS |url=https://www.pelvicorganprolapsesupport.org/sherriepalm-articles/60-minute-mesh-expose |location=[[Racine, Wisconsin]] |publisher=Association for Pelvic Organ Prolapse Support (APOPS) |access-date=February 15, 2022 |archive-date=February 15, 2022 |archive-url=https://web.archive.org/web/20220215230409/https://www.pelvicorganprolapsesupport.org/sherriepalm-articles/60-minute-mesh-expose |url-status=live }}
<!--B-->
* ''Bloomberg''
** {{cite news |ref={{SfnRef|''Bloomberg'' – "Gender-Equality Index"}} |title=Gender-Equality Index |website=Bloomberg Professional Services |url=https://www.bloomberg.com/gei/about/ |access-date=April 16, 2019 |archive-date=April 16, 2019 |archive-url=https://web.archive.org/web/20190416195953/https://www.bloomberg.com/gei/about/ |url-status=live }}
* ''Boson''
** {{Cite magazine |ref={{SfnRef|''Boston'', June 21,|2011}} |magazine=[[Boston (magazine)|Boston]] |last=Elton |first=Catherine |date=June 21, 2011 |title=Boston Scientific and the Road to Ruin |url=https://www.bostonmagazine.com/2011/06/21/boston-scientific-and-the-road-to-ruin/ |access-date=February 16, 2022 |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216152134/https://www.bostonmagazine.com/2011/06/21/boston-scientific-and-the-road-to-ruin/ |url-status=live }}
* {{cite book |title=Business Entity Summary |publisher=[[Massachusetts Secretary of the Commonwealth]]}}
** {{cite web |ref={{SfnRef|Business Entity Summary}} |title=Boston Scientific |type=ID No. 042695240 |url=https://corp.sec.state.ma.us/CorpWeb/CorpSearch/CorpSummary.aspx?sysvalue=9F1bi2NxXImp3HvjQTnxnA-- |access-date=July 6, 2022 |archive-date=July 6, 2022 |archive-url=https://web.archive.org/web/20220706171801/https://corp.sec.state.ma.us/CorpWeb/CorpSearch/CorpSummary.aspx?sysvalue=9F1bi2NxXImp3HvjQTnxnA-- |url-status=live }}
<!--C-->
* {{cite web |ref={{SfnRef|"Consumer Price Index"}} |publisher=[[Federal Reserve Bank of Minneapolis]] |title=Consumer Price Index 1800–{{space|2}} |url=https://www.minneapolisfed.org/about-us/monetary-policy/inflation-calculator/consumer-price-index-1800- |access-date=July 6, 2022 |archive-date=April 29, 2023 |archive-url=https://web.archive.org/web/20230429195918/https://www.minneapolisfed.org/about-us/monetary-policy/inflation-calculator/consumer-price-index-1800- |url-status=live }}
<!--F-->
* ''Forbes''
** {{cite magazine |ref={{SfnRef|''Forbes'', January 19,|2019}} |last1= |magazine=Forbes |last=Valet |first=Vicky |date=January 15, 2019 |title=The Best Employers for Diversity – 2019 Ranking |url=https://www.forbes.com/sites/vickyvalet/2019/01/15/americas-best-employers-for-diversity-2019/?sh=6e9c93192bda |access-date=April 16, 2019 |url-status=dead |archive-url=https://web.archive.org/web/20190116050115/https://www.forbes.com/lists/best-employers-diversity/#7949010d6468 |archive-date=January 16, 2019 |via=[[Internet Archive]] }}
<!--G-->
* ''[[Glassdoor]]''
** (current) {{Cite web |title=Best Places to Work |url=https://www.glassdoor.com/Award/Best-Places-to-Work-LST_KQ0,19.htm |access-date=July 6, 2022 |archive-date=June 5, 2016 |archive-url=https://web.archive.org/web/20160605003448/https://www.glassdoor.com/Award/Best-Places-to-Work-LST_KQ0,19.htm |url-status=live }}
** {{cite web |ref={{SfnRef|''Glassdoor''|2018}} |title=2018 Best Places to Work |quote=Boston Scientific – #35 4.4 stars |url=https://www.glassdoor.com/Award/Best-Places-to-Work-2018-LST_KQ0,24.htm |access-date=July 6, 2022 |archive-date=July 5, 2022 |archive-url=https://web.archive.org/web/20220705223817/https://www.glassdoor.com/Award/Best-Places-to-Work-2018-LST_KQ0,24.htm |url-status=live }}
** {{cite web |ref={{SfnRef|''Glassdoor''|2019}} |title=2019 Best Places to Work |quote=Boston Scientific – #56 4.3 stars |url=https://www.glassdoor.com/Award/Best-Places-to-Work-2019-LST_KQ0,24.htm |access-date=July 6, 2022 |archive-date=July 5, 2022 |archive-url=https://web.archive.org/web/20220705224128/https://www.glassdoor.com/Award/Best-Places-to-Work-2019-LST_KQ0,24.htm |url-status=live }}
** {{cite web |ref={{SfnRef|''Glassdoor''|2022}} |title=Best Places to Work 2022 |quote=Boston Scientific – #52 4.3 stars |url=https://www.glassdoor.com/Award/Best-Places-to-Work-2022-LST_KQ0,24.htm |access-date=August 16, 2023 |archive-date=August 16, 2023 |archive-url=https://web.archive.org/web/20230816160956/https://www.glassdoor.com/Award/Best-Places-to-Work-2022-LST_KQ0,24.htm |url-status=live }}
<!--M-->
* ''Market Realist''
** {{Cite web |ref={{SfnRef|''Market Realist'', May 13,|2016}} |last=Collins |first=Sarah |date=May 13, 2016 |title=Overview of Boston Scientific, a Leading Medical Device Company |url=https://marketrealist.com/2016/05/overview-boston-scientific-leading-medical-device-company/ |access-date=August 6, 2020 |archive-date=January 20, 2021 |archive-url=https://web.archive.org/web/20210120013807/https://marketrealist.com/2016/05/overview-boston-scientific-leading-medical-device-company/ |url-status=live }}
<!--S-->
* ''Strom Law Firm''
** {{Cite web |ref={{SfnRef|Strom, January 25,|2020}} |date=January 25, 2020 |last1=Strom |first1=Pete |title=Boston Scientific to Settle Defective Defibrillator Medicare Fraud Lawsuit |url=https://stromlaw.com/boston-scientific-settle-defective-defibrillator-medicare-fraud-lawsuit/ |access-date=February 16, 2022 |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216161759/https://stromlaw.com/boston-scientific-settle-defective-defibrillator-medicare-fraud-lawsuit/ |url-status=live }}
<!--U-->
* ''US Black Engineer and Information Technology''
** {{cite magazine |ref={{SfnRef|Deen,|2021}} |last=Deen |first=Lango |date=2021 |title=Top Supporters and the Abet-Accredited Engineering Schools at Historically Black Colleges and Universities |magazine=US Black Engineer and Information Technology |volume=45 |issue=2 |pages=24–27 |location=[[Baltimore]] |publisher=Career Communications Group |jstor=48634926 |issn=1088-3444 |oclc=9371713313 |url=https://issuu.com/rjkennedy/docs/usbe_vol45_no2/26?e=33015441 |access-date=July 6, 2022 |via=[[ISSUU]] |archive-date=July 7, 2022 |archive-url=https://web.archive.org/web/20220707000534/https://issuu.com/rjkennedy/docs/usbe_vol45_no2/26?e=33015441 |url-status=live }}
<!--W-->
* ''[[Working Mother]]'' {{ISSN|0278-193X}}; {{OCLC|1054395887}}, {{OCLC search link|937624959}}, {{OCLC search link|16828281}}, {{OCLC search link|1126465630}}, and {{OCLC search link|1113176889}}. The magazine ceased publication in 2021.
** {{cite news |ref={{SfnRef|''Working Mother''|2017}} |date=October–November 2017 |title=100 Best Companies: Highlights |volume=40 |issue=4 |pages=28–29, 82}} {{ProQuest|1942180289}}
** {{cite news |ref={{SfnRef|''Working Mother''|2018}} |date=October–November 2018 |title=100 Best Companies 2018 |volume=41 |issue=4 |pages=38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70}} {{ProQuest|2130239079}}
** {{cite news |ref={{SfnRef|''Working Mother''|2019}} |date=October–November 2019 |title=100 Best Companies 2019 |volume=42 |issue=4 |pages=39–42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62}} {{ProQuest|2305786349}}
** {{cite news |ref={{SfnRef|''Working Mother''|2020}} |date=October–November 2020 |title=TOP 10 Empathetic Employers |volume=43 |issue=4 |pages=18–20, 22–24, 26, 28–30, 32, 34–41}} {{ProQuest|2448689559}}
<!--X-->
* ''[[Xconomy]]''
** {{cite web |ref={{SfnRef|''Xconomy'', August 5,|2008|}} |last=Timmerman |first=Luke |date=August 5, 2008 |title=Boston Scientific Spin-off Aiming to Tap Veins Without Causing Infections |url=https://xconomy.com/boston/2008/08/05/navilyst-medical-boston-scientific-spin-off-aiming-to-tap-veins-without-causing-infections/ |access-date=February 23, 2009 |archive-date=December 2, 2008 |archive-url=https://web.archive.org/web/20081202195929/http://www.xconomy.com/boston/2008/08/05/navilyst-medical-boston-scientific-spin-off-aiming-to-tap-veins-without-causing-infections/ |url-status=live }}
{{refend}}

{{hanging indent |text='''News media (alphabetical by publication/website)'''}}
{{refbegin|30em|indent=yes}}
<!--A-->
* ''[[Atlanta Business Chronicle]]''
** {{cite news |ref={{SfnRef|''Atlanta Business Chronicle'', June 30,|2022}} |work=[[Atlanta Business Chronicle]] |last=Schilling |first=Erin |date=June 30, 2022 |title=Boston Scientific to Open Atlanta Plant |publisher=[[American City Business Journals]] |issn=0164-8071 |url=https://www.bizjournals.com/twincities/news/2022/06/30/boston-scientific-atlanta-plant.html |access-date=July 6, 2022 |archive-date=July 1, 2022 |archive-url=https://web.archive.org/web/20220701073505/https://www.bizjournals.com/twincities/news/2022/06/30/boston-scientific-atlanta-plant.html |url-status=live }} (print ed.).
* ''[[Atlanta Journal-Constitution]]''
** {{Cite news |ref={{SfnRef|''Atlanta Journal-Constitution'', June 28,|2022}} |last1=Kann |first1=Drew |last2=Trubey |first2=J. Scott |date=June 28, 2022 |title=Medical device company plans $62.5 million facility in Johns Creek |work=[[Atlanta Journal-Constitution]] |url=https://www.ajc.com/news/medical-device-company-plans-625-million-facility-in-johns-creek/ADRWLFIQAVEXVDFTQ2ZE4J4ZTM/ |access-date=2022-10-13 |url-access=subscription |issn=1539-7459 |archive-url=https://web.archive.org/web/20220630173823/https://www.ajc.com/news/medical-device-company-plans-625-million-facility-in-johns-creek/ADRWLFIQAVEXVDFTQ2ZE4J4ZTM/ |archive-date=2022-06-30 |url-status=live }}
<!--B-->
* ''BioSpace''
** {{Cite web |ref={{SfnRef|Keown, November 20,|2018}} |last1=Keown |first1=Alex |date=November 20, 2018 |url=https://www.biospace.com/article/boston-scientific-to-acquire-u-k-medical-device-company-btg-for-4-2-billion/ |title=Boston Scientific to Acquire U.K. Medical Device Company BTG for $4.2 Billion |access-date=November 21, 2018 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072705/https://www.biospace.com/article/boston-scientific-to-acquire-u-k-medical-device-company-btg-for-4-2-billion/ |url-status=live }}
** {{Cite web |ref={{SfnRef|Terry, December 28,|2018}} |date=December 28, 2018 |last1=Terry |first1=Mark |url=https://www.biospace.com/article/boston-scientific-buys-millipede-for-325-million/ |title=Boston Scientific Exercises $325 Million Option to Buy Millipede |access-date=January 3, 2019 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072830/https://www.biospace.com/article/boston-scientific-buys-millipede-for-325-million/ |url-status=live }}
* ''[[Bloomberg News]]''
** {{cite news |ref={{SfnRef|''Bloomberg News'', March 2,|2015}} |work=[[Bloomberg News]] |last=McLaughlin |first=Kim |date=March 2, 2015 |title=Boston Scientific Buys Endo Men's Health Unit for $1.6 Billion |url=https://www.bloomberg.com/news/articles/2015-03-02/boston-scientific-buys-endo-men-s-health-unit-for-1-6-billion |url-access=subscription |edition=US |access-date=March 5, 2017 |archive-date=March 4, 2016 |archive-url=https://web.archive.org/web/20160304100048/http://www.bloomberg.com/news/articles/2015-03-02/boston-scientific-buys-endo-men-s-health-unit-for-1-6-billion |url-status=live }} {{EBSCOhost|140889079}}.
* ''[[Boston Business Journal]]''
** {{cite news |ref={{SfnRef|''Boston Business Journal'', March 23,|2021}} |work=[[Boston Business Journal]] |last=Bartlett |first=Jessica |date=March 23, 2021 |title=Boston Scientific Pays $189M to States to Settle Mesh Lawsuits |publisher=[[American City Business Journals]] |url=https://www.bizjournals.com/boston/news/2021/03/23/boston-scientific-pays-189m-to-states-to-settle-m.html |access-date=May 20, 2022 |archive-date=February 13, 2023 |archive-url=https://web.archive.org/web/20230213103025/https://www.bizjournals.com/boston/news/2021/03/23/boston-scientific-pays-189m-to-states-to-settle-m.html |url-status=live }}
<!--C-->
* ''[[CBS News]]''
** {{cite news |ref={{SfnRef|''CBS News'', April 17,|2019}} |work=[[CBS News]] |last=Pelley |first=Scott |author-link=Scott Pelley |date=April 17, 2019 |orig-date=May 13, 2018 |title=Gynecological Mesh: The Medical Device That Has 100,000 Women Suing |url=https://www.cbsnews.com/news/boston-scientific-gynecological-mesh-the-medical-device-that-has-100000-women-suing/ |access-date=May 14, 2018 |quote=A common surgical implant has generated the largest multi-district litigation since asbestos. 60 Minutes reports on one of the device's manufacturers, Boston Scientific, now facing 48,000 lawsuits. |archive-url=https://web.archive.org/web/20180514203837/https://www.cbsnews.com/news/boston-scientific-gynecological-mesh-the-medical-device-that-has-100000-women-suing/ |archive-date=2018-05-14 |url-status=live }}
* ''[[Chicago Tribune]]''
** {{cite news |ref={{SfnRef|''Chicago Tribune'', April 4,|1992|p=2}} |work=[[Chicago Tribune]] |last=Morris |first=Steven |date=April 4, 1992 |title=Sale of Boston Scientific Could Net Abbot $185 Million |url=https://www.newspapers.com/image/389623271/ |url-access=subscription |edition=North Sports Final |volume=145 |issue=95 |page=2 (section 2) |via=[[Newspapers.com]] |access-date=July 6, 2022 |archive-date=July 6, 2022 |archive-url=https://web.archive.org/web/20220706150226/https://www.newspapers.com/image/389623271/ |url-status=live }} {{LCCN|2011267055}}; {{ISSN|1085-6706}} (print); {{OCLC|60639020|show=all}}.<div style="margin-left:6em">({{cite book |title=''article on ''Chicago Tribune's'' blog'' |url=https://www.chicagotribune.com/news/ct-xpm-1992-04-04-9201310173-story.html |date=4 April 1992 |access-date=July 6, 2022 |archive-date=July 6, 2022 |archive-url=https://web.archive.org/web/20220706151733/https://www.chicagotribune.com/news/ct-xpm-1992-04-04-9201310173-story.html |url-status=live }})</div>
* ''[[CNN Business]]''
** {{Cite web |ref={{SfnRef|''CNN Business'', January 14,|2016}} |work=[[CNN Business]] |last=Wattles |first=Jackie |date=January 14, 2016 |title=Boston Scientific Accused of Using Counterfeit Ingredients |url=https://money.cnn.com/2016/01/14/news/companies/boston-scientific-vaginal-mesh/index.html |access-date=February 15, 2022 |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216043022/https://money.cnn.com/2016/01/14/news/companies/boston-scientific-vaginal-mesh/index.html |url-status=live }} {{ProQuest|1756736911}} (US Newsstream database).
<!--F-->
* ''Fierce Biotech''
** {{Cite web |ref={{SfnRef|''Fierce Biotech'', May 25,|2023}} |last=Park |first=Andrea |date=May 25, 2023 |title=Boston Scientific nixes $230M acquisition of stent maker M.I.Tech, citing regulatory roadblocks |website=Fierce Biotech |url=https://www.fiercebiotech.com/medtech/boston-scientific-nixes-230m-acquisition-stentmaker-mitech-citing-regulatory-roadblocks |access-date=June 1, 2023 |archive-date=June 2, 2023 |archive-url=https://web.archive.org/web/20230602050946/https://www.fiercebiotech.com/medtech/boston-scientific-nixes-230m-acquisition-stentmaker-mitech-citing-regulatory-roadblocks |url-status=live }}
<!--G-->
* ''[[The Globe and Mail]]''
** {{cite news |ref={{SfnRef|''Globe and Mail'', October 6,|2021}} |work=[[The Globe and Mail]] |last=Silcoff |first=Sean |date=October 6, 2021 |orig-date=updated October 7, 2021 |title=Ex-Liberal MP Frank Baylis Scores Windfall as Boston Scientific Buys His Heart Device Business for US $1.75-Billion |url=https://www.theglobeandmail.com/business/article-ex-mp-frank-baylis-scores-windfall-as-boston-scientific-buys-his-heart/ |access-date=July 6, 2022 |issn=0319-0714 |archive-date=July 6, 2022 |archive-url=https://web.archive.org/web/20220706194644/https://www.theglobeandmail.com/business/article-ex-mp-frank-baylis-scores-windfall-as-boston-scientific-buys-his-heart/ |url-status=live }}
<!--M-->
* ''MassDevice''
** {{Cite web |ref={{SfnRef|''MassDevice'', December 23,|2009}} |work=MassDevice |date=23 December 2009 |title=Boston Scientific Settles Guidant Kickback Case for $22 Million |url=https://www.massdevice.com/boston-scientific-settles-guidant-kickback-case-22-million/ |access-date=February 16, 2022 |publisher=WTWH Media LLC |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216195839/https://www.massdevice.com/boston-scientific-settles-guidant-kickback-case-22-million/ |url-status=live }}
** {{Cite web |ref={{SfnRef|''MassDevice'', April 6,|2010}} |work=MassDevice |date=April 6, 2010 |title=Guidant Cops Guilty Plea, Makes $296 Million Settlement Official |url=https://www.massdevice.com/guidant-cops-guilty-plea-makes-296-million-settlement-official/ |access-date=February 16, 2022 |publisher=WTWH Media LLC |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216161800/https://www.massdevice.com/guidant-cops-guilty-plea-makes-296-million-settlement-official/ |url-status=live }}
** {{Cite web |ref={{SfnRef|''MassDevice'', June 9,|2010}} |work=MassDevice |last=Perriello |first=Brad |date=June 9, 2010 |title=MassDevice Q&A: Boston Scientific Co-Founder John Abele |url=https://www.massdevice.com/massdevice-qa-boston-scientific-co-founder-john-abele/ |access-date=July 6, 2022 |publisher=WTWH Media LLC |archive-date=July 6, 2022 |archive-url=https://web.archive.org/web/20220706175237/https://www.massdevice.com/massdevice-qa-boston-scientific-co-founder-john-abele/ |url-status=live }}
** {{Cite web |ref={{sfnref|''MassDevice'', August 27,|2016}} |work=MassDevice |last=Perriello |first=Brad |date=2016-09-27 |title=Boston Scientific to pay $210m for EndoChoice |url=https://www.massdevice.com/boston-scientific-pay-210m-endochoice/ |access-date=2022-10-13 |publisher=WTWH Media LLC |archive-date=October 13, 2022 |archive-url=https://web.archive.org/web/20221013192602/https://www.massdevice.com/boston-scientific-pay-210m-endochoice/ |url-status=live }}
** {{Cite web |ref={{SfnRef|''MassDevice'', May 14,|2018}} |work=MassDevice |last=Densford |first=Fink |date=May 14, 2018 |title=Update: ''60 Minutes'' Report Claims Unapproved Plastic Sources Used in Boston Scientific Pelvic Meshes |url=https://www.massdevice.com/60-minutes-report-claims-unapproved-plastic-sources-used-in-boston-scientific-pelvic-meshes/ |access-date=February 15, 2022 |publisher=WTWH Media LLC |archive-date=February 15, 2022 |archive-url=https://web.archive.org/web/20220215230409/https://www.massdevice.com/60-minutes-report-claims-unapproved-plastic-sources-used-in-boston-scientific-pelvic-meshes/ |url-status=live }}
* ''Medical Device and Diagnostic Industry (MD+DI)''
** {{Cite web |ref={{SfnRef|Ford, July 22,|2020}} |last=Ford |first=Omar |date=2020-07-22 |title=Boston Sci Wins Nod for Next Gen Watchman Device |website=Medical Device and Diagnostic Industry (MD+DI) |url=https://www.mddionline.com/cardiovascular/boston-sci-wins-nod-next-gen-watchman-device |access-date=2022-10-13 |archive-date=October 13, 2022 |archive-url=https://web.archive.org/web/20221013192802/https://www.mddionline.com/cardiovascular/boston-sci-wins-nod-next-gen-watchman-device |url-status=live }}
* ''[[Medscape]]''
** {{cite web |ref={{SfnRef|Wood, March 4,|2004}} |last1=Wood |first1=Shelley |date=March 4, 2004 |title=FDA Approves Taxus Paclitaxel-Eluting Stent |website=Medscape |url=http://www.medscape.com/viewarticle/784821 |access-date=February 20, 2015 |archive-date=August 11, 2019 |archive-url=https://web.archive.org/web/20190811175448/https://www.medscape.com/viewarticle/784821 |url-status=live }}
* ''MedTech Intelligence''
** {{Cite web |ref={{SfnRef|''MedTech Intelligence'', March 23,|2021}} |date=March 23, 2021 |title=Boston Scientific Settles Surgical Mesh Claims for Nearly $189 Million |website=MedTech Intelligence |publisher=Innovative Publishing Company, Inc. |url=https://www.medtechintelligence.com/news_article/boston-scientific-settles-surgical-mesh-claims-for-nearly-189-million/ |access-date=February 15, 2022 |archive-date=February 15, 2022 |archive-url=https://web.archive.org/web/20220215225318/https://www.medtechintelligence.com/news_article/boston-scientific-settles-surgical-mesh-claims-for-nearly-189-million/ |url-status=live }}
<!--N-->
* ''[[NBC News]]''
** {{cite news |ref={{SfnRef|''NBC News'', January 25,|2006}} |work=[[NBC News]] |date=January 25, 2006 |title=Guidant Battle Ends in Favor of Boston Scientific |url=https://www.nbcnews.com/id/wbna11018335 |type=[[Associated Press|AP]] |access-date=February 11, 2008 |archive-date=October 29, 2020 |archive-url=https://web.archive.org/web/20201029172244/https://www.nbcnews.com/id/wbna11018335 |url-status=live }}
* ''[[The New York Times]]''
** {{cite news |ref={{SfnRef|''New York Times'', October 10,|1995|p=4D}} |agency=[[Reuters]] |date=October 10, 1995 |title=Company News; Boston Scientific to Acquire EP Technologies |work=[[The New York Times]] |edition=Late (East Coast) |volume=145 |issue=50210 |page=4 (section D) |url=https://www.nytimes.com/1995/10/10/business/company-news-boston-scientific-to-acquire-ep-technologies.html |access-date=July 7, 2022 |url-access=subscription |archive-url=https://web.archive.org/web/20220707185710/https://www.nytimes.com/1995/10/10/business/company-news-boston-scientific-to-acquire-ep-technologies.html |archive-date=July 7, 2022 |url-status=deviated }} (alternate access → {{cite news |title=''permalink'' |work=[[The New York Times]] |url=https://nyti.ms/3NLxSwl |url-access=subscription |via=[[TimesMachine]]) |access-date=July 7, 2022 |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135110/https://timesmachine.nytimes.com/timesmachine/1995/10/10/501995.html?zoom=15.31 |url-status=live }} {{ProQuest|430375451}}, {{ProQuest|430365512}} (US Newsstream database)
* ''NS Medical Devices ''
** {{cite web |ref={{SfnRef|''NS Medical Devices'', November 20,|2019}} |date=November 20, 2019 |title=Baring Private Equity Asia to Buy Lumenis in $1bn Deal |url=https://www.nsmedicaldevices.com/news/baring-lumenis-1bn/ |access-date=July 6, 2022 |archive-date=July 8, 2022 |archive-url=https://web.archive.org/web/20220708075132/https://www.nsmedicaldevices.com/news/baring-lumenis-1bn/ |url-status=live }}
<!--R-->
* ''[[Reuters]]''
** {{cite news |ref={{SfnRef|''Reuters'', November 19,|2014}} |work=[[Reuters]] |last=Ax |first=Joseph |date=November 19, 2014 |title=J&J Seeks Over $5 Billion in Damages From Boston Scientific at Trial |url=https://www.reuters.com/article/us-johnson-johnson-boston-scient-trial-idUSKCN0J30CS20141119 |archive-url=https://web.archive.org/web/20151020023313/http://www.reuters.com/article/2014/11/19/us-johnson-johnson-boston-scient-trial-idUSKCN0J30CS20141119 |archive-date=October 20, 2015 }}
** {{cite news |ref={{SfnRef|''Reuters'', May 28, 2015}} |work=[[Reuters]] |last=Dye |first=Jessica |date=May 28, 2015 |title=Boston Scientific Ordered to Pay $100 Million in Transvaginal Mesh Trial |url=https://www.reuters.com/article/us-boston-scientific-mesh-verdict/boston-scientific-ordered-to-pay-100-million-in-transvaginal-mesh-trial-idUSKBN0OD27L20150528 |access-date=May 14, 2018 |archive-date=May 15, 2018 |archive-url=https://web.archive.org/web/20180515112300/https://www.reuters.com/article/us-boston-scientific-mesh-verdict/boston-scientific-ordered-to-pay-100-million-in-transvaginal-mesh-trial-idUSKBN0OD27L20150528 |url-status=live }}
** {{Cite news |ref={{SfnRef|''Reuters'', October 9,|2015}} |work=[[Reuters]] |last=Dye |first=Jessica |date=October 9, 2015 |title=Boston Scientific Mesh Verdict Slashed to $10 Million |url=https://www.reuters.com/article/us-boston-scient-mesh-verdict-idUSKCN0S329320151009 |access-date=February 15, 2022 |archive-date=February 15, 2022 |archive-url=https://web.archive.org/web/20220215220748/https://www.reuters.com/article/us-boston-scient-mesh-verdict-idUSKCN0S329320151009 |url-status=live }}
** {{Cite news |ref={{SfnRef|''Reuters'', October 6,|2021}} |work=[[Reuters]] |date=October 6, 2021 |title=Boston Scientific to Buy Baylis Medical for $1.75 Billion |url=https://www.reuters.com/article/baylis-medical-company-m-a-boston/boston-scientific-to-buy-baylis-medical-for-1-75-billion-idUSKBN2GW11D |access-date=October 8, 2021 |archive-date=October 6, 2021 |archive-url=https://web.archive.org/web/20211006221218/https://www.reuters.com/article/baylis-medical-company-m-a-boston/boston-scientific-to-buy-baylis-medical-for-1-75-billion-idUSKBN2GW11D |url-status=live }}
<!--S-->
* ''[[Sacramento Business Journal]]''
** {{cite journal |ref={{SfnRef|''Sacramento Business Journal'', March 23,|2008}} |journal=[[Sacramento Business Journal]] |date=March 23, 2008 |title=Boston Scientific Sells off Santa Rosa Division |publisher=[[American City Business Journals]] |url=https://www.bizjournals.com/sacramento/stories/2008/03/31/daily1.html |access-date=July 7, 2022 |archive-date=February 13, 2023 |archive-url=https://web.archive.org/web/20230213103648/https://www.bizjournals.com/sacramento/stories/2008/03/31/daily1.html |url-status=live }}
* ''[[Seattle Times]]''
** {{cite news |ref={{SfnRef|''Seattle Times'', August 13,|2011|p=}} |work=[[Seattle Times]] |last=Bernton |first=Hal |date=August 13, 2011 |title=Army Whistle-Blower Fights to Clear Name |url=https://www.seattletimes.com/seattle-news/army-whistle-blower-fights-to-clear-name/ |page=1 |access-date=July 6, 2022 |archive-date=July 5, 2022 |archive-url=https://web.archive.org/web/20220705224934/https://www.seattletimes.com/seattle-news/army-whistle-blower-fights-to-clear-name/ |url-status=live }}
<!--W-->
* ''[[Wall Street Journal]]''
** {{cite news |ref={{SfnRef|''Wall Street Journal'', February 2,|2010}} |work=Wall Street Journal |last=Kamp |first=Jon |date=February 2, 2010 |title=Boston Scientific to Pay J&J $1.73B to Settle Stent Patent Disputes |volume=255 |issue=26 |page=B3 |url=https://www.wsj.com/articles/SB10001424052748704107204575039430685168478 |url-access=subscription |access-date=August 12, 2017 |archive-date=August 2, 2020 |archive-url=https://web.archive.org/web/20200802160716/https://www.wsj.com/articles/SB10001424052748704107204575039430685168478 |url-status=live }} {{EBSCOhost|48080573}}.
{{refend}}

{{hanging indent |text='''Press releases (alphabetical by date)'''}}
{{refbegin|30em|indent=yes}}
<!--U-->
* {{Cite press release |ref={{SfnRef|U.S. Department of Justice, January 12,|2011}} |publisher=[[U.S. Department of Justice]] |date=January 12, 2011 |title=Medical Device Manufacturer Guidant Sentenced for Failure to Report Defibrillator Safety Problems to FDA |url=https://www.justice.gov/opa/pr/medical-device-manufacturer-guidant-sentenced-failure-report-defibrillator-safety-problems |access-date=February 16, 2022 |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216161808/https://www.justice.gov/opa/pr/medical-device-manufacturer-guidant-sentenced-failure-report-defibrillator-safety-problems |url-status=live }}
* {{Cite press release |ref={{SfnRef|U.S. Department of Justice, January 27,|2011}} |publisher=[[U.S. Department of Justice]] |date=January 27, 2011 |title=United States Files Suit Against Guidant and Boston Scientific for Selling Defective Heart Devices That Were Implanted in Medicare Patients |url=https://www.justice.gov/opa/pr/united-states-files-suit-against-guidant-and-boston-scientific-selling-defective-heart |access-date=February 16, 2022 |archive-date=February 16, 2022 |archive-url=https://web.archive.org/web/20220216161818/https://www.justice.gov/opa/pr/united-states-files-suit-against-guidant-and-boston-scientific-selling-defective-heart |url-status=live }}
{{refend}}

{{hanging indent |text='''Primary sources via Boston Scientific'''}}
{{refbegin|30em|indent=yes}}
<!--no date-->
* {{cite news |ref={{SfnRef|"About Boston Scientific"}} |title=About Boston Scientific" → "Corporate Overview" → "Our History |url=https://www.bostonscientific.com/en-US/about-us.html |access-date=February 20, 2015 |archive-date=February 19, 2015 |archive-url=https://web.archive.org/web/20150219045913/http://www.bostonscientific.com/en-US/about-us.html |url-status=live }}
* {{Cite web |ref={{SfnRef|"Diversity & Inclusion"}} |url=https://www.bostonscientific.com/en-US/careers/working-here/diversity-and-inclusion.html |title=Diversity & Inclusion |access-date=April 17, 2019 |year=2018 |archive-date=April 17, 2019 |archive-url=https://web.archive.org/web/20190417111345/https://www.bostonscientific.com/en-US/careers/working-here/diversity-and-inclusion.html |url-status=live }}
* {{cite news |ref={{SfnRef|Diversity, May 2,|2022}} |date=May 2, 2022 |title=Boston Scientific Named a Best Employer for Diversity in 2022 |url=https://news.bostonscientific.com/Boston-Scientific-Named-Best-Employer-For-Diversity-2022 |access-date=July 5, 2022 |archive-date=July 5, 2022 |archive-url=https://web.archive.org/web/20220705191941/https://news.bostonscientific.com/Boston-Scientific-Named-Best-Employer-For-Diversity-2022 |url-status=live }}

<!--2000s-->
* {{Cite news |ref={{SfnRef|Precision Vascular Systems, April 7,|2004}} |date=April 7, 2004 |title=Boston Scientific Announces Acquisition of Precision Vascular Systems, Inc. |url=https://news.bostonscientific.com/news-releases?item=58711 |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135953/https://news.bostonscientific.com/news-releases?item=58711 |url-status=live }}
* {{Cite news |ref={{SfnRef|Advanced Bionics Corporation, June 1,|2004}} |date=June 1, 2004 |title=Boston Scientific Announces Acquisition of Advanced Bionics Corporation |url=https://news.bostonscientific.com/news-releases?item=58598 |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140011/https://news.bostonscientific.com/news-releases?item=58598 |url-status=live }}
* {{Cite news |ref={{SfnRef|Advanced Stent Technologies, December 16,|2004}} |date=December 16, 2004 |title=Boston Scientific Enters Into Definitive Agreement to Acquire Advanced Stent Technologies, Inc. |url=https://news.bostonscientific.com/news-releases?item=58759 |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135953/https://news.bostonscientific.com/news-releases?item=58759 |url-status=live }}
* {{Cite web |ref={{SfnRef|TriVascular, April 18,|2005}} |date=April 18, 2005 |url=https://news.bostonscientific.com/news-releases?item=58659 |title=Boston Scientific Announces Acquisition of TriVascular, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135947/https://news.bostonscientific.com/news-releases?item=58659 |url-status=live }}
* {{Cite web |ref={{SfnRef|CryoVascular Systems, April 18,|2005}} |date=April 18, 2005 |url=https://news.bostonscientific.com/news-releases?item=58648 |title=Boston Scientific Announces Decision to Acquire CryoVascular Systems |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135949/https://news.bostonscientific.com/news-releases?item=58648 |url-status=live }}
* {{Cite web |ref={{SfnRef|Rubicon Medical Corporation, June 14,|2005}} |date=June 14, 2005 |url=https://news.bostonscientific.com/news-releases?item=58780 |title=Boston Scientific Completes Accquisition of Rubicon Medical Corporation |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140016/https://news.bostonscientific.com/news-releases?item=58780 |url-status=live }}
* {{Cite web |ref={{SfnRef|Guidant, January 8,|2006}} |date=January 8, 2006 |url=https://news.bostonscientific.com/news-releases?item=58725 |title=Boston Scientific Submits Definitive Offer to Acquire Guidant for $72 Per Share in Cash and Stock |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140013/https://news.bostonscientific.com/news-releases?item=58725 |url-status=live }}

<!--2020s-->
* {{cite news |ref={{SfnRef|"EMBLEM S–ISC System,"|2020}} |date=2020 |orig-date=2016 |title=EMBLEM S–ICD System – Subcutaneous Implantable Defibrillator}}
<ol type="i" start="1">
<li> {{cite web |title=EMBLEM S–ICD System – Model A209 |url=http://www.bostonscientific.com/en-US/products/defibrillators/emblem-s-icd-system.html |access-date=February 26, 2016 |archive-url=https://web.archive.org/web/20160226180051/http://www.bostonscientific.com/en-US/products/defibrillators/emblem-s-icd-system.html |archive-date=February 26, 2016 }}</li>
<li> {{cite web |title=EMBLEM MRI S–ICD System: Model A219 |url=https://www.bostonscientific.com/en-US/products/defibrillators/emblem-s-icd-system/device-overview/specifications.html |access-date=June 22, 2022 |archive-date=June 22, 2022 |archive-url=https://web.archive.org/web/20220622221732/https://www.bostonscientific.com/en-US/products/defibrillators/emblem-s-icd-system/device-overview/specifications.html |url-status=live }}</li>
</ol>
* {{cite web |ref={{SfnRef|"2021 Performance Report"}} |title=2021 Performance Report – Advancing Science for Life |url=https://www.bostonscientific.com/content/dam/bostonscientific/corporate/corporate-responsibility/performance-report/2021_boston_scientific_performance_report.pdf |access-date=July 9, 2022 |archive-date=July 9, 2022 |archive-url=https://web.archive.org/web/20220709195924/https://www.bostonscientific.com/content/dam/bostonscientific/corporate/corporate-responsibility/performance-report/2021_boston_scientific_performance_report.pdf |url-status=live }}
* {{cite web |ref={{SfnRef|''3BL CSRwire'', May 5,|2022}} |website=3BL CSRwire |date=May 5, 2022 |title=Boston Scientific Named a Best Employer for Diversity in 2022 |url=https://www.csrwire.com/press_releases/743711-boston-scientific-named-best-employer-diversity-2022 |access-date=July 9, 2022 |archive-date=July 9, 2022 |archive-url=https://web.archive.org/web/20220709194730/https://www.csrwire.com/press_releases/743711-boston-scientific-named-best-employer-diversity-2022 |url-status=live }}
{{refend}}

{{hanging indent |text='''Primary sources via ''PR Newswire'' (by date)'''}}
{{refbegin|30em|indent=yes}}
* {{cite news |ref={{SfnRef|Irregularities in Japanese Subsidiary, November 3,|1998}} |date=November 3, 1998 |title=Boston Scientific Addresses Japan Business Irregularities |url=http://www.thefreelibrary.com/Boston+Scientific+Addresses+Japan+Business+Irregularities.-a053164699 |url-status=dead |archive-url=https://web.archive.org/web/20150214120843/http://www.thefreelibrary.com/Boston+Scientific+Addresses+Japan+Business+Irregularities.-a053164699 |archive-date=February 14, 2015 |via=The Free Library }} {{ProQuest|447205826}}
* {{cite web |ref={{SfnRef|Guidant, April 21,|2006}} |date=April 21, 2006 |title=Boston Scientific Completes Combination with Guidant |url=https://news.bostonscientific.com/news-releases?item=58835 |access-date=February 11, 2008 |archive-date=May 10, 2021 |archive-url=https://web.archive.org/web/20210510143254/https://news.bostonscientific.com/news-releases?item=58835 |url-status=live }}
* {{Cite web |ref={{SfnRef|Fluid Management & Venous Access, December 13,|2007}} |date=December 13, 2007 |url=https://news.bostonscientific.com/news-releases?item=59017 |title=Boston Scientific Agrees to Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million |access-date=May 20, 2022 |archive-date=July 8, 2022 |archive-url=https://web.archive.org/web/20220708073550/https://news.bostonscientific.com/news-releases?item=59017 |url-status=live }}
* {{Cite web |ref={{SfnRef|TriVascular (sale of BSSR), March 31,|2008}} |date=March 31, 2008 |url=https://news.bostonscientific.com/news-releases?item=59041 |title=Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program |access-date=July 7, 2022 |archive-date=January 12, 2022 |archive-url=https://web.archive.org/web/20220112053928/https://news.bostonscientific.com/news-releases?item=59041 |url-status=live }}
* {{Cite web |ref={{SfnRef|CryoCor Merger, April 16,|2008}} |date=April 16, 2008 |url=https://news.bostonscientific.com/news-releases?item=59050 |title=Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135916/https://news.bostonscientific.com/news-releases?item=59050 |url-status=live }}
* {{Cite web |ref={{SfnRef|CryoCor, May 28,|2008}} |date=May 28, 2008 |url=https://news.bostonscientific.com/news-releases?item=59071 |title=Boston Scientific Completes Acquisition of CryoCor |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140010/https://news.bostonscientific.com/news-releases?item=59071 |url-status=live }}
* {{Cite web |ref={{SfnRef|Labcoat Ltd., January 6,|2009}} |date=January 6, 2009 |url=https://news.bostonscientific.com/news-releases?item=59112 |title=Boston Scientific Acquires Labcoat Limited |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135949/https://news.bostonscientific.com/news-releases?item=59112 |url-status=live }}
* {{Cite web |ref={{SfnRef|Asthmatx, October 26,|2010}} |date=October 26, 2010 |url=https://news.bostonscientific.com/news-releases?item=59276 |title=Boston Scientific Completes Acquisition of Asthmatx |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135942/https://news.bostonscientific.com/news-releases?item=59276 |url-status=live }}
* {{Cite web |ref={{SfnRef|Neurovascular business, January 3,|2011}} |date=January 3, 2011 |url=https://news.bostonscientific.com/news-releases?item=59289 |title=Boston Scientific Completes Sale of Neurovascular Business |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135942/https://news.bostonscientific.com/news-releases?item=59289 |url-status=live }}
* {{Cite web |ref={{SfnRef|Sadra Medical, January 4,|2011}} |date=January 4, 2011 |url=https://news.bostonscientific.com/news-releases?item=59290 |title=Boston Scientific Completes Acquisition of Sadra Medical |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135918/https://news.bostonscientific.com/news-releases?item=59290 |url-status=live }}
* {{Cite web |ref={{SfnRef|Intelect Medical, January 5,|2011}} |date=January 5, 2011 |url=https://news.bostonscientific.com/news-releases?item=59292 |title=Boston Scientific Acquires Intelect Medical |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135920/https://news.bostonscientific.com/news-releases?item=59292 |url-status=live }}
* {{Cite web |ref={{SfnRef|Atritech, January 19,|2011}} |date=January 19, 2011 |url=https://news.bostonscientific.com/news-releases?item=59294 |title=Boston Scientific to Acquire Atritech |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135919/https://news.bostonscientific.com/news-releases?item=59294 |url-status=live }}
* {{cite news |ref={{SfnRef|Cameron Health, June 8,|2012}} |date=June 8, 2012 |title=Boston Scientific Closes Cameron Health Acquisition |url=http://www.prnewswire.com/news-releases/boston-scientific-closes-cameron-health-acquisition-158187505.html |access-date=February 26, 2016 |archive-date=August 11, 2019 |archive-url=https://web.archive.org/web/20190811175459/https://www.prnewswire.com/news-releases/boston-scientific-closes-cameron-health-acquisition-158187505.html |url-status=live }}
* {{Cite web |ref={{SfnRef|BridgePoint Medical, September 19,|2012}} |date=September 19, 2012 |url=https://news.bostonscientific.com/2012-09-19-Boston-Scientific-to-Acquire-BridgePoint-Medical-Inc. |title=Boston Scientific to Acquire BridgePoint Medical, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135926/https://news.bostonscientific.com/2012-09-19-Boston-Scientific-to-Acquire-BridgePoint-Medical-Inc. |url-status=live }}
* {{Cite web |ref={{SfnRef|Rhythmia Medical, October 8,|2012}} |date=October 8, 2012 |url=https://news.bostonscientific.com/2012-10-08-Boston-Scientific-to-Acquire-Rhythmia-Medical-Inc. |title=Boston Scientific to Acquire Rhythmia Medical, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140014/https://news.bostonscientific.com/2012-10-08-Boston-Scientific-to-Acquire-Rhythmia-Medical-Inc. |url-status=live }}
* {{Cite web |ref={{SfnRef|Vessix Vascular, November 8,|2012}} |date=November 8, 2012 |url=https://news.bostonscientific.com/2012-11-08-Boston-Scientific-to-Acquire-Vessix-Vascular-Inc. |title=Boston Scientific to Acquire Vessix Vascular, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140018/https://news.bostonscientific.com/2012-11-08-Boston-Scientific-to-Acquire-Vessix-Vascular-Inc. |url-status=live }}
* {{Cite web |ref={{SfnRef|C.R. Bard Electrophysiology, June 28,|2013}} |date=June 28, 2013 |url=https://news.bostonscientific.com/2013-06-28-Boston-Scientific-To-Acquire-C-R-Bard-Electrophysiology-Business |title=Boston Scientific to Acquire C.R. Bard Electrophysiology Business |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140005/https://news.bostonscientific.com/2013-06-28-Boston-Scientific-To-Acquire-C-R-Bard-Electrophysiology-Business |url-status=live }}
* {{Cite web |ref={{SfnRef|Bard Electrophysiology, November 1,|2013}} |date=November 1, 2013 |url=https://news.bostonscientific.com/2013-11-01-Boston-Scientific-Completes-Acquisition-Of-Bard-Electrophysiology |title=Boston Scientific Completes Acquisition of Bard Electrophysiology |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140017/https://news.bostonscientific.com/2013-11-01-Boston-Scientific-Completes-Acquisition-Of-Bard-Electrophysiology |url-status=live }}
* {{Cite web |ref={{SfnRef|IoGyn, May 6,|2014}} |date=May 6, 2014 |url=https://news.bostonscientific.com/2014-05-06-Boston-Scientific-To-Acquire-IoGyn-Inc |title=Boston Scientific to Acquire IoGyn, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135951/https://news.bostonscientific.com/2014-05-06-Boston-Scientific-To-Acquire-IoGyn-Inc |url-status=live }}
* {{Cite web |ref={{SfnRef|Bayer Interventional Business, September 2,|2014}} |date=September 2, 2014 |url=https://news.bostonscientific.com/2014-09-02-Boston-Scientific-Closes-Acquisition-Of-Interventional-Business-Of-Bayer-AG |title=Boston Scientific Closes Acquisition of Interventional Business of Bayer AG |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140012/https://news.bostonscientific.com/2014-09-02-Boston-Scientific-Closes-Acquisition-Of-Interventional-Business-Of-Bayer-AG |url-status=live }}
* {{Cite web |ref={{SfnRef|Xlumena, April 1,|2015}} |date=April 1, 2015 |url=https://news.bostonscientific.com/2015-04-01-Boston-Scientific-Agrees-to-Acquire-Xlumena |title=Boston Scientific Agrees to Acquire Xlumena |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135950/https://news.bostonscientific.com/2015-04-01-Boston-Scientific-Agrees-to-Acquire-Xlumena |url-status=live }}
* {{Cite web |ref={{SfnRef|MValve Technologies, October 8,|2015}} |date=October 8, 2015 |url=https://news.bostonscientific.com/2015-10-08-Boston-Scientific-Announces-Additional-Investment-And-Right-To-Acquire-MValve-Technologies |title=Boston Scientific Announces Additional Investment and Right to Acquire MValve Technologies |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140015/https://news.bostonscientific.com/2015-10-08-Boston-Scientific-Announces-Additional-Investment-And-Right-To-Acquire-MValve-Technologies |url-status=live }}
* {{Cite web |ref={{SfnRef|Cosman Medical, July 27,|2016}} |date=July 27, 2016 |url=https://news.bostonscientific.com/2016-07-27-Boston-Scientific-Announces-Acquisition-of-Cosman-Medical |title=Boston Scientific Announces Acquisition of Cosman Medical |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135918/https://news.bostonscientific.com/2016-07-27-Boston-Scientific-Announces-Acquisition-of-Cosman-Medical |url-status=live }}
* {{Cite web |ref={{SfnRef|Resectr™ Tissue Resection Device, November 15,|2016}} |date=November 15, 2016 |url=https://news.bostonscientific.com/2016-11-15-Boston-Scientific-Acquires-Resectr-Tissue-Resection-Device-from-Distal-Access-LLC |title=Boston Scientific Acquires Resectr™ Tissue Resection Device From Distal Access, LLC |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135959/https://news.bostonscientific.com/2016-11-15-Boston-Scientific-Acquires-Resectr-Tissue-Resection-Device-from-Distal-Access-LLC |url-status=live }}
* {{Cite web |ref={{SfnRef|EndoChoice, November 22,|2016}} |date=November 22, 2016 |url=https://news.bostonscientific.com/2016-11-22-Boston-Scientific-Closes-EndoChoice-Acquisition |title=Boston Scientific Closes EndoChoice Acquisition |access-date=May 20, 2022 |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135110/https://news.bostonscientific.com/2016-11-22-Boston-Scientific-Closes-EndoChoice-Acquisition |url-status=live }}
* {{Cite web |ref={{SfnRef|Neovasc Advanced Biological Tissue, December 12,|2016}} |date=December 12, 2016 |url=https://news.bostonscientific.com/2016-12-02-Boston-Scientific-Announces-Agreement-to-Acquire-Neovasc-Advanced-Biological-Tissue-Capabilities |title=Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135914/https://news.bostonscientific.com/2016-12-02-Boston-Scientific-Announces-Agreement-to-Acquire-Neovasc-Advanced-Biological-Tissue-Capabilities |url-status=live }}
* {{Cite web |ref={{SfnRef|Symetis, May 16,|2017}} |date=May 16, 2017 |url=https://news.bostonscientific.com/2017-05-16-Boston-Scientific-Closes-Symetis-Acquisition |title=Boston Scientific Closes Symetis Acquisition |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135917/https://news.bostonscientific.com/2017-05-16-Boston-Scientific-Closes-Symetis-Acquisition |url-status=live }}
* {{Cite web |ref={{SfnRef|Apama Medical, October 2,|2017}} |date=October 2, 2017 |url=https://news.bostonscientific.com/2017-10-02-Boston-Scientific-Announces-Agreement-to-Acquire-Apama-Medical |title=Boston Scientific Announces Agreement to Acquire Apama Medical |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140007/https://news.bostonscientific.com/2017-10-02-Boston-Scientific-Announces-Agreement-to-Acquire-Apama-Medical |url-status=live }}
* {{Cite web |ref={{SfnRef|Securus Medical Group, April 3,|2018}} |date=April 3, 2018 |url=https://news.bostonscientific.com/2018-04-03-Boston-Scientific-Announces-Acquisition-of-Securus-Medical-Group-Inc |title=Boston Scientific Announces Acquisition of Securus Medical Group, Inc. |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520140009/https://news.bostonscientific.com/2018-04-03-Boston-Scientific-Announces-Acquisition-of-Securus-Medical-Group-Inc |url-status=live }}
* {{Cite web |ref={{SfnRef|nVision Medical, April 16,|2018}} |date=April 16, 2018 |url=https://news.bostonscientific.com/2018-04-16-Boston-Scientific-Announces-Acquisition-Of-nVision-Medical-Corporation |title=Boston Scientific Announces Acquisition of nVision Medical Corporation |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135952/https://news.bostonscientific.com/2018-04-16-Boston-Scientific-Announces-Acquisition-Of-nVision-Medical-Corporation |url-status=live }}
* {{Cite web |ref={{SfnRef|NxThera, April 30,|2018}} |date=April 30, 2018 |url=https://news.bostonscientific.com/2018-04-30-Boston-Scientific-Closes-NxThera-Acquisition |title=Boston Scientific Closes NxThera Acquisition |access-date=May 20, 2022 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135916/https://news.bostonscientific.com/2018-04-30-Boston-Scientific-Closes-NxThera-Acquisition |url-status=live }}
{{refend}}

{{hanging indent |text='''Primary sources via ''BioSpace'' (by date)'''}}
{{refbegin|30em|indent=yes}}
* {{cite web |ref={{SfnRef|Cryterion Medical, July 5,|2018}} |date=July 5, 2018 |title=Boston Scientific to Acquire Cryterion Medical, Inc. |url=https://www.biospace.com/article/boston-scientific-to-acquire-cryterion-medical-inc-/ |access-date=September 24, 2018 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072832/https://www.biospace.com/article/boston-scientific-to-acquire-cryterion-medical-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Claret Medical, August 2,|2018}} |date=August 2, 2018 |url=https://www.biospace.com/article/boston-scientific-closes-acquisition-of-claret-medical-inc-announces-positive-reimbursement-decision/ |title=Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision |access-date=October 21, 2018 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072728/https://www.biospace.com/article/boston-scientific-closes-acquisition-of-claret-medical-inc-announces-positive-reimbursement-decision/ |url-status=live }}
* {{cite web |ref={{SfnRef|VENITI, August 8,|2018}} |date=August 8, 2018 |title=Boston Scientific Announces Agreement to Acquire VENITI, Inc. |url=https://www.biospace.com/article/boston-scientific-announces-agreement-to-acquire-veniti-inc-/ |access-date=October 21, 2018 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072733/https://www.biospace.com/article/boston-scientific-announces-agreement-to-acquire-veniti-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Augmenix, October 16,|2018}} |url=https://www.biospace.com/article/boston-scientific-closes-acquisition-of-augmenix-inc-/ |date=October 16, 2018 |title=Boston Scientific Closes Acquisition of Augmenix, Inc. |access-date=October 21, 2018 |archive-date=January 4, 2019 |archive-url=https://web.archive.org/web/20190104072813/https://www.biospace.com/article/boston-scientific-closes-acquisition-of-augmenix-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Vertiflex, May 9,|2019}} |date=May 9, 2019 |url=https://www.biospace.com/article/boston-scientific-announces-agreement-to-acquire-vertiflex-inc-/ |title=Boston Scientific Announces Agreement to Acquire Vertiflex, Inc. |access-date=June 2, 2019 |archive-date=June 2, 2019 |archive-url=https://web.archive.org/web/20190602135018/https://www.biospace.com/article/boston-scientific-announces-agreement-to-acquire-vertiflex-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Preventice Solutions, January 21,|2021}} |date=January 21, 2021 |url=https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-preventice-solutions-inc-/ |title=Boston Scientific Announces Agreement to Acquire Preventice Solutions, Inc |access-date=January 21, 2021 |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135111/https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-preventice-solutions-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Lumenis Surgical Business, March 3,|2021}} |date=March 3, 2021 |url=https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-lumenis-ltd-surgical-business-from-baring-private-equity-asia/ |title=Boston Scientific Announces Agreement to Acquire Lumenis Ltd. Surgical Business From Baring Private Equity Asia |access-date=March 4, 2021 |archive-date=June 22, 2022 |archive-url=https://web.archive.org/web/20220622203250/https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-lumenis-ltd-surgical-business-from-baring-private-equity-asia/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Farapulse, June 24,|2021}} |url=https://www.biospace.com/article/boston-scientific-exercises-option-to-acquire-farapulse-inc-/ |date=June 24, 2021 |title=Boston Scientific Exercises Option to Acquire Farapulse, Inc. |access-date=June 30, 2021 |archive-date=May 20, 2022 |archive-url=https://web.archive.org/web/20220520135904/https://www.biospace.com/article/boston-scientific-exercises-option-to-acquire-farapulse-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Devoro Medical, September 21,|2021}} |date=September 21, 2021 |url=https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-devoro-medical-inc-/ |title=Boston Scientific Announces Agreement to Acquire Devoro Medical, Inc |access-date=September 23, 2021 |archive-date=September 23, 2021 |archive-url=https://web.archive.org/web/20210923214829/https://www.biospace.com/article/releases/boston-scientific-announces-agreement-to-acquire-devoro-medical-inc-/ |url-status=live }}
* {{Cite web |ref={{SfnRef|M.I.Tech Co., June 15,|2022}} |date=June 15, 2022 |title=Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd From Synergy Innovation Co., Ltd |url=https://www.biospace.com/article/boston-scientific-announces-agreement-to-purchase-majority-stake-of-m-i-tech-co-ltd-from-synergy-innovation-co-ltd/ |access-date=June 16, 2022 |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135111/https://www.biospace.com/article/boston-scientific-announces-agreement-to-purchase-majority-stake-of-m-i-tech-co-ltd-from-synergy-innovation-co-ltd/ |url-status=live }}
* {{Cite web |ref={{SfnRef|Obsidio, August 15,|2022}} |date=June 15, 2022 |title=Boston Scientific Announces Acquisition of Obsidio, Inc. |url=https://www.biospace.com/article/releases/boston-scientific-announces-acquisition-of-obsidio-inc-/ |access-date=August 15, 2022 |archive-date=August 15, 2022 |archive-url=https://web.archive.org/web/20220815164150/https://www.biospace.com/article/releases/boston-scientific-announces-acquisition-of-obsidio-inc-/ |url-status=live }}
{{refend}}

{{hanging indent |text='''Primary sources – financials'''}}
{{refbegin|30em|indent=yes}}
<!--B-->
* {{Cite book |title=''Boston Scientific'' Annual Reports }}
<ol type="i" start="1">
<li> {{Cite book |ref={{SfnRef|''BSC Annual Report'',|2019|p=}} |title=''2019'' |url=https://www.bostonscientific.com/content/dam/bostonscientific/corporate/annual-report/2019_Boston_Scientific_Annual_Report.pdf |access-date=July 7, 2022 |archive-date=June 1, 2024 |archive-url=https://web.archive.org/web/20240601135110/https://www.bostonscientific.com/content/dam/bostonscientific/corporate/annual-report/2019_Boston_Scientific_Annual_Report.pdf |url-status=live }}</li>
<li> {{Cite book |ref={{SfnRef|''BSC Annual Report'',|2020|loc=Exhibit 21}} |title=''2020'' |url=https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/annual-reports-proxy-statements/2020-boston-scientific-annual-report.pdf |access-date=July 7, 2022 |archive-date=February 13, 2023 |archive-url=https://web.archive.org/web/20230213105402/https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/annual-reports-proxy-statements/2020-boston-scientific-annual-report.pdf |url-status=live }}</li>
<li> {{Cite book |ref={{SfnRef|''BSC Annual Report'',|2021|p=}} |title=''2021'' |url=https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/2021_Boston_Scientific_Annual_Report.pdf |access-date=July 7, 2022 |archive-date=May 12, 2022 |archive-url=https://web.archive.org/web/20220512081321/https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/2021_Boston_Scientific_Annual_Report.pdf |url-status=live }}</li>
<li> {{Cite book |ref={{SfnRef|''BSC Annual Report'',|2022|p=}} |title=''2022'' |url=https://www.bostonscientific.com/content/dam/bostonscientific/corporate/annual-report/2022-Boston-Scientific-annual-report.pdf.coredownload.pdf |access-date=2023-08-16 |archive-date=July 5, 2023 |archive-url=https://web.archive.org/web/20230705091042/https://www.bostonscientific.com/content/dam/bostonscientific/corporate/annual-report/2022-Boston-Scientific-annual-report.pdf.coredownload.pdf |url-status=live }}</li>
</ol>
* {{Cite web |title=Boston Scientific Corp |website=SEC Report |url=https://sec.report/CIK/0000885725 |access-date=2022-09-21 |ref={{sfnref|SEC Report|}} |url-status=dead |archive-date=2022-09-21 |archive-url=https://web.archive.org/web/20220921195325/https://sec.report/CIK/0000885725 }}
* {{cite book |title=''Boston Scientific → [[Form 10-K]]s (fiscal year-end: December 31)'' |publisher=[[U.S. Securities and Exchange Commission]] }}
<ol type="i" start="1">
<li> {{cite book |ref={{SfnRef|"Form 10K," December 31,|2024}} |title=''December 31, 2024'' |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/885725/000088572525000011/bsx-20241231.htm |type=filed February 18, 2025 |access-date=February 19, 2025 }}</li>
</ol>
{{refend}}

==External links==
* {{URL|https://www.bostonscientific.com|Official website}}
{{Finance links
| name = Boston Scientific
| symbol = BSX
| reuters = BSX.N
| bloomberg = BSX:US
| sec_cik = 885725
| yahoo = BSX
| google = BSX:NYSE

}}
* {{hanging indent |text={{cite news |ref={{SfnRef|''Boston Globe'', May 17,|2005|p=F5}}|last1=''Boston Globe'' (''The'') |author-link1=The Boston Globe |last2=Kerber |first2=Ross |date=May 17, 2005 |title=Gamble Wins Big at Boston Scientific – Stent Maker Soars Despite Major Recall |url=https://archive.boston.com/business/globe/articles/2005/05/17/gamble_wins_big_at_boston_scientific_stent_maker_soars_despite_major_recall/ |series={{free access}} |volume=267 |issue=137 |page=F5 |access-date=March 12, 2006 |issn=0743-1791}} (publication); {{ProQuest|404957389}} (US Newsstream database) (alternate access → via {{cite book |last1=Newspapers.com |author-link1=Newspapers.com |title=''link'' |url=https://www.newspapers.com/image/443613257/ |url-access=subscription |access-date=July 7, 2022 }}).}}

{{Authority control}}

[[Category:Boston Scientific| ]]
[[Category:Companies listed on the New York Stock Exchange]]
[[Category:Manufacturing companies based in Massachusetts]]
[[Category:American companies established in 1979]]
[[Category:Technology companies established in 1979]]
[[Category:Health care companies based in Massachusetts]]
[[Category:Companies based in Middlesex County, Massachusetts]]
[[Category:Marlborough, Massachusetts]]
[[Category:Life science companies based in Massachusetts]]
[[Category:Implants (medicine)]]
[[Category:Medical technology companies of the United States]]
[[Category:Health care companies established in 1979]]
[[Category:Technology companies based in Massachusetts]]
[[Category:1979 establishments in Massachusetts]]
[[Category:1992 initial public offerings]]
[[Category:American brands]]